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The cellular environment presents a protein with many small molecules with which it 
may interact. Many novel interactions between proteins and non-substrate metabolites are 
being uncovered through proteome-wide screens. The homodimeric Escherichia coli 
cofactor-dependant phosphoglycerate mutase (dPGM) was identified as an ATP binding 
protein in a proteome-wide screen, but dPGM does not use ATP for catalysis. This 
dissertation elucidates the effect of ATP and other non-substrate metabolites on dPGM. 
Initial investigations revealed a partially unfolded, monomeric intermediate of dPGM that 
forms during equilibrium unfolding. ATP binding was found to occur at the active site of 
dPGM and to be energetically coupled with dimerization; ligand binding events reduce 
the population of intermediate. An investigation into the structure of the dPGM 
intermediate revealed a cooperative folding unit that couples the active site and dimer 
interface of dPGM. By coupling the two binding sites, the cooperative unit is responsible 
for conveying the allosteric effect observed between dimerization and ligand binding. We 
found that physiological salts reduce but do not prevent non-substrate metabolite binding 





was found to bind to both of the energetically coupled sites on dPGM, the active site and 
dimer interface. Our findings illustrate how a cooperative link between a ligand binding 
site and oligomer interface can promote higher order oligomers and reduce intermediate 
populations. The physiological effect of the cooperative link and ligand binding to dPGM 
is a large enhancement in the stability of the dimer over the monomer intermediate and, 






CHAPTER 1. INTRODUCTION 
1.1 The thermodynamics of protein folding 
Proteins are essential biopolymers that carryout chemical reactions, conduct chemical 
signaling, and provide structural support to the cell. Proteins are dynamic molecules and 
their function typically requires folding to the proper three dimensional conformations. In 
the early 1960s, pioneering work from by Christian B. Anfinsen and colleagues 
investigated the reversible folding of ribonuclease and poly-DL-alanyl trypsin and 
formed the basis of the thermodynamic hypothesis (Anfinsen, Haber, Sela, & White, 
1961; Epstein & Anfinsen, 1962). The thermodynamic hypothesis is the idea that protein 
folding is governed by thermodynamics, and that proteins fold to the lowest energy 
conformation (Anfinsen, 1973). Levinthal showed that proteins must fold through certain 
routes due to kinetic barriers because a random search for the native state is not feasible 
given vast number of possible conformations (Levinthal, 1968).  
 
Currently, protein folding is viewed as movement of the protein along the surface of a 
three-dimensional, funnel-shaped energy landscape (Dill & Chan, 1997). Every point 
along the funneled energy landscape represents a protein conformation. The vertical axis 
(z-axis) of the funnel corresponds to the internal energy of a conformation; the bottom of 





represents the high-energy, globally unfolded form. The lateral axes, in the X−Y plane, 
define different conformational coordinates of the protein and reflect the numerous 
degrees of freedom of the protein chain (Dill & Chan, 1997). Protein folding is similar to 
a ball rolling down the funneled energy landscape; the protein will move to lower energy 
conformations and travel via the lowest energy routes. Protein are jostled about the 
energy landscape by Brownian motion so once the protein reaches the bottom of the 
funnel, the native state, the protein will continue to undergo some conformational 
fluctuation. The energy landscape can be smooth, which indicates a protein will fold 
cooperatively from the unfolded to native forms with no detectable intermediate; an 
energy landscape can also be rough and contain small wells, local minima, that represent 
low-energy intermediate conformations (Dill & Chan, 1997). Even under native 
conditions a protein exists as a conformational ensemble with the population of each 
conformation determined by the energy landscape (Dill & Chan, 1997; Frauenfelder, 
Sligar, & Wolynes, 1991; Hilser, Garcia-Moreno, Oas, Kapp, & Whitten, 2006). 
Conformational fluctuations manifest themselves as dynamic motions on the picosecond 
to millisecond timescales and are often necessary for the biochemical function of a 
protein (Hammes, 2002; Henzler-Wildman & Kern, 2007). The distribution of 
conformations in the ensemble of a protein gives rise to the macroscopic properties 
observed by traditional biophysical probes such as spectroscopy or calorimetry.  
 
1.2 Cooperativity and allostery in protein 
Although the energy landscape of a protein encodes a vast number of conformations, in 





2013). Residues throughout a protein may be energetically coupled so that a perturbation 
to one, affects the other (Hilser, Dowdy, Oas, & Freire, 1998; T. Liu, Whitten, & Hilser, 
2007). This coupling between residues can lead to them to fold and unfold in concert 
(positive cooperativity), or one residue may unfold when the other folds (negative 
cooperativity). The cooperative folding of proteins is an emergent property that arises 
from the energetic coupling between residues (Ernesto. Freire, Murphy, Sanchez-Ruiz, 
Galisteo, & Privalov, 1992; Gunasekaran, Ma, & Nussinov, 2004; T. Liu et al., 2007). 
Coupling between residues shapes the energy landscape and causes many proteins to fold 
as a hierarchical assembly of individual cooperative units (Bai, Sosnick, Mayne, & 
Englander, 1995; Chamberlain, Handel, & Marqusee, 1996; Hu et al., 2013). Folding 
cooperativity is important for reducing non-functional intermediate conformations that 
may misfold (Dobson, 2003) or aggregate (Horwich, 2002). Mutations in a protein can 
reshape the energy landscape and make intermediate forms more favorable or alter the 
folding pathway, ultimately promoting disease. The ΔF08 mutation in the cystic fibrosis 
receptor (CFTR) is a seminal example of how a single mutation can severely impair 
folding; with the ΔF08 mutation, CFTR does not fold to the native form and is degraded 
in the cytoplasm, giving rise to cystic fibrosis (Lukacs & Verkman, 2012).  
 
Whether proteins truly fold through multiple pathways, as implied by the funnel-model 
(Dill & Chan, 1997; Dill, Ozkan, Shell, & Weikl, 2008) is debatable. Experiments that 
tend to support multiple folding routes (Mello & Barrick, 2004; Sridevi, Lakshmikanth, 
Krishnamoorthy, & Udgaonkar, 2004; Zhong, Rousseau, & Yeh, 2004) may be explained 





(Englander, Mayne, & Krishna, 2007; Hu, Kan, Mayne, & Englander, 2016). The energy 
landscape of the Notch ankyrin repeat domain was experimentally mapped using a series 
of truncated mutants and appeared to show multiple low-energy folding routes (Mello & 
Barrick, 2004). When folding of the full length Notch ankyrin repeat domain was 
investigated, the protein was found to fold via one discrete pathway (Bradley & Barrick, 
2006). Ribonuclease H (Hu et al., 2013) and Cytochrome c (Hu et al., 2016) also fold 
through one discrete pathway in which the cooperative subunits of the protein fold one at 
a time, and in the same order. The sequential folding of the subunits that make up 
Ribonuclease H and Cytochrome c was observed at near amino acid resolution by 
hydrogen/deuterium exchange coupled with mass spectrometry. From the proteins that 
were studied at an adequate level of detail thus far, protein appear to have evolved so the 
folding of the initial cooperative unit stabilizes the next cooperative unit and so on, which 
naturally gives rise to a linear folding pathway. However, these proteins are also small 
and are likely to fold well in comparison to much of the proteome. In fact, model proteins 
used for folding studies are highly biased towards well-folding, monomeric protein 
compared to the distribution of protein in the E. coli proteome (Braselmann, Chaney, & 
Clark, 2013).  
 
The energetic coupling between residues in a protein is also responsible for allosteric 
regulation of a protein (Lockless & Ranganathan, 1999). Allostery is an fundamental 
feature of protein in which two binding sites, distal to one another, are energetically 
coupled so that binding at one site influences binding at the other (Gunasekaran et al., 





binding remodels a protein’s energy landscape, causing a redistribution of the 
conformational ensemble that affects binding at a second site (Smock & Gierasch, 2009; 
Weber, 1972). In this way, binding of one ligand can promote conformations with greater 
or lesser affinity for the second ligand. Here, the ligand may also be another protein 
rather than a small molecule. For example, the dopamine and somatostatin receptors have 
been shown to form a heterodimer that exhibits greatly enhanced activity (Rocheville et 
al., 2000). The allosteric behavior of the dopamine and somatostatin receptors is driven 
by the protein−protein interaction. Allosteric coupling is crucial for control of molecular 
processes such as protein signaling (Chennubhotla, Yang, & Bahar, 2008; Ernesto Freire, 
1999; Harford & Weitzman, 1975; Hynes, 2002; Yu et al., 2010) and autoinhibition (Yu 
et al., 2010). Non-allosteric protein have been found to have hidden allosteric sites which 
suggests that all dynamic protein are allosteric (Gunasekaran et al., 2004). Then, 
understanding allosteric effects and cooperativity within protein will facilitate an 
understanding of typical protein behavior. 
 
The use of allosteric effects is a promising avenue for drug development (Berger et al., 
1999; Kalid et al., 2010; Kenakin, 2002). Synthetic antibodies have been evolved through 
phage display to trap protein in specific conformations and could be used to promote 
active or inactive conformations of a protein without binding to the active site (Paduch et 
al., 2013). Pharmacological chaperones are small molecule drugs that either facilitate the 
proper folding of a protein or stabilize the protein in its folded form (Ringe & Petsko, 
2009). Gaucher disease is a lysosomal storage disorder that is triggered by mutations in 





mutation has impaired folding and trafficking. The small molecule isofagomine is able to 
bind in the active site of N370S acid β-glucosidase and shift the protein ensemble to the 
active conformation, which restores proper cellular trafficking (Lieberman et al., 2007). 
Efforts are underway to develop a pharmacological chaperone for ΔF508 CFTR (Kalid et 
al., 2010; Robert et al., 2010; Van Goor et al., 2006); however, the chaperones are not yet 
effective at restoring CFTR activity (Lukacs & Verkman, 2012). Deciphering the basis of 
allostery and cooperativity within proteins is a key challenge for the understanding and 
prediction of protein behavior and the treatment of disease.  
 
1.3 Energetics based proteomics 
Ligand binding shifts a protein ensemble to binding competent forms. Because ligand 
binding enhances the conformational stability of the binding competent forms, the 
energetics of ligand binding can be determined from changes in protein stability 
(Sanchez-Ruiz, 2007; Schellman, 1976; Waldron & Murphy, 2003). Often the stabilizing 
effect of ligand binding protects protein against proteolytic degradation (Pace & Barrett, 
1984; Sieber, Pluckthun, & Schmid, 1998; Walter et al., 1999). Either partial or global 
unfolding of a protein is required for a protease to cleave the polypeptide chain (Park & 
Marqusee, 2004b). By utilizing the change in the proteolytic susceptibility of a protein 
upon unfolding, Park and Marqusee developed the technique, pulse proteolysis to 
determine the global stability of proteins (Park & Marqusee, 2005). For pulse proteolysis, 
a high concentration of a non-specific protease is used to selectively digest unfolded 
protein in one short pulse of digestion. A short pulse length is essential to the technique 





reaction. In this way, the unfolded proteins at a set point in time are selectively digested 
and the folded protein may be visualized (Park & Marqusee, 2005). Because proteins do 
not re-equilibrate during the proteolytic digestion, pulse proteolysis is analogous to taking 
a photograph of the folding protein population. When pulse proteolysis is conducted with 
a series of samples that span a range of urea concentrations, the amount of folded protein 
at each urea concentration is determined. From the dependence of the folded protein 
population on urea, the global stability can be determined (Greene & Pace, 1974; Pace, 
1986). Through determination of the global stability of a protein in the absence and 
presence of a ligand, pulse proteolysis can report on changes in global stability incurred 
by ligand binding (Park & Marqusee, 2005). Pulse proteolysis is also extremely useful for 
monitoring protein stability in complex samples. When using pulse proteolysis, proteins 
can be separated after the reaction by techniques such as SDS-PAGE, eliminating the 
need for protein purification in order to quantify global stability. Through the use of 
western blotting, the global stability of human H-ras was compared and found to be the 
same in cell lysate from Escherichia coli and Jurkat T cells by pulse proteolysis (Kim, 
Song, & Park, 2009).  
 
Unlike traditional methods based on spectroscopy or calorimetry, pulse proteolysis 
permits the study of protein unfolding for many proteins simultaneously on a proteomic 
scale (Adhikari & Fitzgerald, 2014; Chang, Schlebach, VerHeul, & Park, 2012; P.-F. Liu, 
Kihara, & Park, 2011). The ability to add protease to any sample, followed by gel-based 
visualization makes pulse proteolysis a simple tool to implement on a proteomic scale. 





binding protein (P.-F. Liu et al., 2011). To identify ATP binding protein, samples of E. 
coli lysate were prepared in 3M urea in the presence and absence of 1.0 mM ATPγS. The 
concentration of free ATP in E. coli is thought be about 1 mM (Schneider & Gourse, 
2004). Pulse proteolysis was carried out on each sample and the intact protein was 
separated and visualized by 2D-gel electrophoresis. Here, determination of global 
stability is not required to identify proteins that interact with ATP. A large difference in 
band intensity for the same protein in the absence and presence of ATP signifies that the 
protein interacts with ATP (Chang et al., 2012; P.-F. Liu et al., 2011). Ten ATP-binding 
proteins, including four novel ATP-binding proteins were identified (P.-F. Liu et al., 
2011). To facilitate better visualization of protein and expand target-identification 
capabilities, the E. coli proteome was again probed for ATP binding but after the lysate 
was fractionated by ion exchange chromatography so proteins could be visualized by 1D 
SDS-PAGE (Chang et al., 2012). In this screen, the proteome was assayed by pulse 
proteolysis at multiple urea concentrations in the absence and presence of 1.0 mM ATPγS, 
which allowed the detection of additional ATP-binding proteins; thirty ATP-binding 
proteins, including nine novel ATP-binding proteins, were identified (Chang et al., 2012). 
One of the novel ATP-binding proteins was cofactor-dependent phosphoglycerate mutase 
(dPGM). At 2.0 M urea, dPGM was fully disgusted in the absence of ATP, but a 
significant population of folded protein remained when 1.0 mM ATPγS was present 
(Chang et al., 2012).  
 
The denaturant dependence of methionine oxidation in the presence of hydrogen peroxide 





only be oxidized when it is unfolded or solvent exposed so oxidation events should 
indicate unfolding. Changes in the oxidation rate in the presence of a ligand can be used 
to determine protein−ligand interactions (West et al., 2010). By combining stable isotope 
labeling in culture and mass spectrometry, changes in the methionine oxidation of a 
protein in the presence of a ligand can be determined in complex samples (Tran, Adhikari, 
& Fitzgerald, 2014). Methionine oxidation of the proteome of Saccharomyces cerevisiae 
was monitored in the presence and absence ATPγS to identify ATP binding protein (Tran 
et al., 2014). From the proteomic-screen, ATP was found to also stabilize S. cerevisiae 
dPGM. The dPGM from E. coli and S. cerevisiae both appear to be a novel ATP binding 
protein, as ATP has no known role in their catalytic activities. Then, ATP could have an 
allosteric effect upon the dPGMs and a novel binding site. 
 
1.4 Cofactor-dependant phosphoglycerate mutases  
Phosphoglycerate mutase proteins are found in two unrelated classes: cofactor-
independent and cofactor-dependant. Most vertebrate, yeast, and bacteria possess a 
cofactor-dependant phosphoglycerate mutase (dPGM) (Fraser, Kvaratskhelia, & White, 
1999; Grisolia & Joyce, 1959). The cofactor-dependency of phosphoglycerate mutase 
refers to the fact that mutase activity of dPGM requires phosphorylation of a conserved 
histidine (His10, E. coli numbering) within the active site by the cofactor 2,3-
bisphosphoglycerate (2,3-BPG) (Fraser et al., 1999; Grisolia & Cleland, 1968). This 
histidine and a conserved catalytic core make dPGM a member of the histidine 
phosphatase superfamily, which includes enzymes such as fructose-2,6-bisphosphatase, 






fulfils its role as a histidine phosphatase (EC 3.1.3.13) and catalyzes the transfer of a 
phosphoryl group from the cofactor, 2,3-BPG, to the active-site histidine, which yields a 
molecule of 2-phosphoglycerate or 3-phosphoglycerate. The phosphorylated dPGM is 
primed for its mutase activity (E.C. 5.4.2.11) and can catalyze the essential isomerization 
reaction between 2- and 3-phosphoglycerate in the glycolysis and gluconeogenesis 
pathways. Lastly, dPGM has been reported to function as a synthase (E.C. 5.4.2.4) and 
form 2,3-BPG in the presence of 1,3-bisphosphoglycerate and 3-phosphoglycerate 
(Laforet, Butterfield, & Alpers, 1974).  
 
After E. coli dPGM was found to bind ATP in the proteomic screen, the stabilization of 
dPGM by ATP was confirmed by performing pulse proteolysis with purified dPGM 
(Chang et al., 2012). The E. coli dPGM is a homodimer consisting of 249-amino-acid 
monomers with a molecular weight of 28.4 kDa (Fraser et al., 1999). The 
crystallographic structures of both active and inactive E. coli dPGM have been solved 
(Bond, White, & Hunter, 2001, 2002). When dPGM is activated, the C-terminal tail folds 
over the active site entrance and forms interactions with residues along the active-site rim 
(Bond et al., 2001). Aside from the folding of the C-terminal tail, there are few structural 
differences between the structures of active and inactive dPGM. The active form of 
dPGM shows two sulfate ions bound within the active site (Bond et al., 2001), and the 
inactive form bound tetravanadate in the active site (Bond et al., 2002). The active site of 
dPGM appears rather accommodating, which raises the question of whether ATP can 
bind in the active site and whether such binding would be productive. The activity of 






& Britton, 1974; Fraser et al., 1999; Grisolia & Cleland, 1968; Laforet et al., 1974; Rose 
& Dube, 1978; Rose & Kaklij, 1984; Vander Heiden et al., 2010; Winn, Watson, Harkins, 
& Fothergill, 1981). The phosphatase and mutase activities of dPGMs are sensitive to the 
presence of anions and especially divalent anions, which function as competitive 
inhibitors (Grisolia & Cleland, 1968; Kowalski, Nocon, Gamian, Kołodziej, & Rakus, 
2012; Rose & Dube, 1978; Rose & Kaklij, 1984). ATP, however, has not been observed 
to play a role in the activity of a dPGM.  
 
1.5 Investigating the energetics and of non-substrate metabolite binding and the 
folding of E. coli phosphoglycerate mutase 
ATP was observed to enhance the stability of E. coli dPGM at a physiological 
concentration, which suggests that the interaction may occur in the cytosol. The 
stabilizing effect of ATP was determined by pulse proteolysis, which cannot discriminate 
between cleavable intermediate forms and the globally unfolded protein. Also, a protein 
could undergo conformational change without becoming susceptible to protease, which is 
invisible to pulse proteolysis. In this dissertation, the results show that proteolysis of 
dPGM occurred through a partially unfolded intermediate. We observe that ATP binding 
can induce a large shift in the conformational ensemble of dPGM and promote 
dimerization. The ligand binding and dimerization events are allosteric. Our results reveal 
how an allosteric effect can be intrinsic to the folding of an oligomeric protein and 
demonstrate the important role that the physiological milieu can have in reducing protein 
intermediates. We have also extended the use of equilibrium φ-analysis (Campos, Bueno, 






intermediate of an oligomer using only chemical denaturation. Determination of the 
structure of an intermediate by equilibrium φ-analysis can be useful to identify 
energetically coupled sites in a protein, which may assist the development of an allosteric 
drug.  
 
In chapter 2, we investigate the effect of ligand binding on the equilibrium unfolding of 
dPGM to understand how ATP affects the stability of dPGM. A partially unfolded, 
monomeric intermediate of dPGM was found to be populated during equilibrium 
unfolding. Nucleotides, including ATP, and phosphates significantly enhance the stability 
of dimeric dPGM over the intermediate. Equilibrium unfolding of dPGM in the presence 
of 1.0 mM ATP appears cooperative. Through ligand docking and mutagenesis, ATP was 
determined to bind the active site of dPGM. Our results indicated that ligand binding at 
the active site is energetically coupled with dimerization such that they display positive 
allostery.  
 
Chapter 3 reveals the structure of the dPGM intermediate to discern the cooperative 
network of secondary structural units that couple ligand binding at the active site and 
dimerization. Through extensive mutagenesis and equilibrium unfolding, equilibrium φ-
values were determined for residues throughout the dPGM structure. The equilibrium φ-
values report on whether side-chain contacts are maintained or lost in the intermediate 
state (Campos et al., 2004). Hydrogren/deuterium exchange (HDX) revealed differences 
in solvent exposure of the peptide backbone between native dPGM and the intermediate. 






that is unfolded in the intermediate state, and underlies the allostery observed between 
ligand binding at the active site and dimerization. 
 
In chapter 4, we investigate the effect of non-substrate metabolite binding to dPGM in the 
physiological milieu to understand whether it has functional consequences. A range of 
metabolites are found to stabilize dPGM but the presence of salt, especially Mg2+, 
reduces metabolite binding. The effect of salt itself on dPGM is stabilizing and promotes 
the dimer over the monomeric intermediate. The effect of salt on several dPGM variants 
reveals that chloride binds at either end of the cooperative network in dPGM: the active 
site and the dimer interface. For many metabolites and salts, the effects we observed 
occur at physiologically relevant concentrations. Our results suggest that the chemical 
environment of the E. coli cytosol would be highly stabilizing for dPGM and metabolites 
and anions may cause competitive inhibition.  
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CHAPTER 2.  ENERGETIC COUPLING BETWEEN LIGAND BINDING AND 
DIMERIZATION IN ESCHERICHIA COLI PHOSPHOGLYCERATE MUTASE1 
2.1 Summary 
Energetic coupling of two molecular events in a protein molecule is ubiquitous in 
biochemical reactions mediated by proteins, such as catalysis and signal transduction. 
Here, we investigate energetic coupling between ligand binding and folding of a dimer 
using a model system that shows three-state equilibrium unfolding of an exceptional 
quality. The homodimeric Escherichia coli cofactor-dependent phosphoglycerate mutase 
(dPGM) was found to be stabilized by ATP in a proteome-wide screen, although dPGM 
does not require or utilize ATP for enzymatic function. We investigated the effect of ATP 
on the thermodynamic stability of dPGM using equilibrium unfolding. We found that, in 
the absence of ATP, dPGM populates a partially unfolded, monomeric intermediate 
during equilibrium unfolding. However, addition of 1.0 mM ATP drastically reduces the 
population of the intermediate by selectively stabilizing the native dimer. Using a 
computational ligand docking method, we predicted ATP binds to the active site of the 
enzyme using the triphosphate group. By performing equilibrium unfolding and 
isothermal titration calorimetry with active-site variants of dPGM, we confirmed that 
active-site residues are involved in ATP binding. Our findings show that ATP promotes 
dimerization of the protein by binding to the active site, which is distal from the dimer 






the dimer interface. We also propose a structural link to explain how ligand binding to the 
active site is energetically coupled with dimerization.  
 
2.2 Introduction 
Cooperativity between two events occurring at two distant sites is a salient feature of 
protein molecules. Protein folding is a cooperative process where a group of structural 
units in a protein fold or unfold simultaneously (Ernesto Freire & Murphy, 1991). Due to 
the cooperative nature, conformational energy landscapes of proteins are composed of 
discrete partially unfolded forms rather than a continuum of possible conformations (Bai 
et al., 1995; Chamberlain et al., 1996; Hu et al., 2013). Ligand binding events at two 
different binding sites in a protein are frequently cooperative; binding of one ligand 
positively or negatively influences binding of the other ligand. The cooperative binding 
of two ligands is the basis of allostery (Hilser & Thompson, 2007; Motlagh, Wrabl, Li, & 
Hilser, 2014), which is commonly observed in many aspects of cellular processes, such as 
catalysis and signal transduction. The fundamental principle of cooperativity is the same 
whether observed in ligand binding or in protein folding (Luque, Leavitt, & Freire, 2002). 
Ligand binding as well as folding/unfolding of a region modulates the conformational 
energy landscape of a protein. The change in the energy and the population of various 
conformations results in the changes in macroscopic structural properties in proteins. The 
structural changes can be as subtle as changes in side-chain dynamics or as drastic as 
folding of unstructured domains (Motlagh et al., 2014). Understanding the energetic basis 







From our previous proteomics study, we identified a protein that shows a remarkable 
energetic coupling between ligand binding and folding. Previously, we conducted an 
energetics-based proteome screen to identify ATP-binding proteins in the E. coli 
proteome (Chang et al., 2012; P.-F. Liu et al., 2011). This proteome screen exploits the 
fact that ligand binding stabilizes proteins (Sanchez-Ruiz, 2007; Schellman, 1976; 
Waldron & Murphy, 2003). We subjected proteins in an E. coli lysate to urea unfolding 
in the presence and absence of 1.0 mM ATPγS and compared the amount of proteins that 
remain intact after pulse proteolysis (Chang et al., 2012; P.-F. Liu et al., 2011). Pulse 
proteolysis is a way to monitor protein unfolding by selectively digesting the unfolded 
proteins through a brief incubation with a non-specific protease (Park & Marqusee, 2005). 
Different from traditional methods based on spectroscopy or calorimetry, pulse 
proteolysis allows us to study unfolding of many proteins simultaneously on a proteomic 
scale (Adhikari & Fitzgerald, 2014; Chang et al., 2012; P.-F. Liu et al., 2011). At 2.0 M 
urea, cofactor-dependent phosphoglycerate mutase (dPGM) was fully digested without 
ATP, but a significant population of the protein remained intact in the presence of 1.0 
mM ATPγS (Chang et al., 2012). E. coli dPGM is a homodimer consisting of 249-amino-
acid subunits with the molecular weight of 28.4 kDa. Interestingly, dPGM does not 
require ATP for its enzyme activity. However, we confirmed the stabilization of dPGM 
in the presence of 1.0 mM ATP by performing pulse proteolysis with purified dPGM 
(Chang et al., 2012). Later, the Fitzgerald group reported that ATP also stabilizes S. 








Phosphoglycerate mutases (E.C. 5.4.2.11) catalyze the essential isomerization reaction 
between 3-phosphoglycerate and 2-phosphoglycerate in the glycolysis and 
gluconeogenesis pathways. Most vertebrate, yeast, and bacteria possess a cofactor-
dependant phosphoglycerate mutase (dPGM) that must be activated by the cofactor 2,3-
bisphosphoglycerate (2,3-BPG) (Bond et al., 2001). In the activating reaction, dPGM 
serves as a phosphatase (EC 3.1.3.13) for 2,3-BPG and converts 2,3-BPG into 2-
phosphoglycerate or 3-phosphoglycerate while retaining a phosphate group on an active-
site histidine residue. In the isomerization reaction, the phosphate group on the 
phosphohistidine of the activated enzyme is transferred to 2-phosphoglycerate or 3-
phosphoglycerate, and the resulting 2,3-BPG is used to phosphorylate the histidine 
residue. Through this process, dPGM shuttles a phosphate group between 3-
phosphoglycerate and 2-phosphoglycerate.  
 
To quantitatively assess the effect of ATP on the stability of this enzyme, we monitored 
urea-induced equilibrium unfolding of E. coli dPGM using fluorescence and circular 
dichroism. In the absence of ATP, equilibrium unfolding of dPGM reveals two well-
separated transitions with an equilibrium intermediate, indicating that dPGM unfolds in a 
three-state manner. Interestingly, we found that the equilibrium intermediate disappears 
in the presence of ATP; dPGM unfolds in a two-state manner without any observable 
equilibrium intermediate upon binding to ATP. Realizing that this protein is an excellent 
model system to understand the molecular mechanism for the energetic coupling between 
ligand binding and folding, we decided to investigate how ATP binding promotes 






to dissect the molecular details of the interaction between dPGM and ATP and the 
energetic coupling between ATP binding and dPGM folding. Based on our experimental 
data, we propose a structural model for the cooperativity between folding of the active 
site and the dimer interface.  
 
2.3 Results  
2.3.1 Equilibrium unfolding of dPGM in the presence and absence of ATP  
We monitored equilibrium unfolding of dPGM in the absence and presence of 1.0 mM 
ATP by intrinsic tryptophan fluorescence (Figure 2.1A). From the fluorescence emission 
spectrum at each urea concentration, we calculate one intensity-weighted average 
wavelength (IWAW). When dPGM unfolds and its tryptophans become more solvent-
exposed, IWAW shifts to longer wavelengths. Immediately apparent in Figure 2.1A is 
that equilibrium unfolding of dPGM occurs in a three-state manner in the absence of ATP. 
A shoulder occurs between 2 M and 3 M urea with the IWAW value of about 355 nm, 
signifying that an intermediate state with properties distinct from the native and unfolded 
states is populated. The first unfolding transition has the transition midpoint (Cm) of ~1.4 
M urea and occurs with a signal change that is about 70 % of the total change in 
fluorescence. The second unfolding transition has a Cm value of ~3.5 M urea. We also 
monitored the equilibrium unfolding of dPGM by circular dichroism (Figure 2.2). The 
two transitions observed by CD occur with the same Cm values as those observed by 
fluorescence, suggesting that we are observing the same and only equilibrium 
intermediate. The first transition occurs with 35% of the total change in CD signal upon 






secondary structure as well as significant changes in the environment around tryptophan 
residues.  
 
In the presence of 1.0 mM ATP, equilibrium unfolding of dPGM occurs in only one 
apparent transition with a Cm of about 3.6 M urea without any indication of an 
equilibrium intermediate (Figure 2.1A). The addition of 1.0 mM ATP not only stabilizes 
dPGM dramatically but also suppresses accumulation of the equilibrium intermediate. 
Due to strong UV absorption by ATP, equilibrium unfolding of dPGM in the presence of 
1.0 mM ATP could not be monitored by CD.  
 
2.3.2 Oligomeric state of the equilibrium intermediate  
Developing a model to analyze the equilibrium unfolding of a dimeric protein with an 
equilibrium intermediate requires knowledge of whether the intermediate is a monomer 
or a dimer. First, we investigated the oligomeric state of the intermediate of dPGM 
through the dependence of equilibrium unfolding on the protein concentration. As the 
protein concentration is increased, dimeric states should be stabilized due to Le 
Chatelier’s principle. Therefore, a transition that shows a dependence on the protein 
concentration involves a change in oligomeric state from dimer to monomer. When we 
monitored equilibrium unfolding of dPGM with three different concentrations of dPGM 
(10, 30 and 100 μg/mL), we clearly observed that, as the protein concentration increases, 
the apparent Cm value of the first transition gradually increases as well (Figure 2.3A). 
The second transition does not exhibit any observable dependency on the protein 






dPGM by circular dichroism (CD), which confirmed the concentration dependence of the 
first transition (Figure 2.4). The concentration dependence of equilibrium unfolding best 
supports a monomer intermediate.  
 
We further examined the oligomeric state of the intermediate by chemical cross-linking 
with BS(PEG)5, which reacts selectively with amine groups. After dPGM was incubated 
with BS(PEG)5 in varying concentrations of urea (0 – 5 M), the cross-linked samples 
were visualized by SDS-PAGE (Figure 2.3B). Without urea, the dPGM dimer and 
monomer bands are both visible and migrate with apparent molecular weights of ~60 kDa 
and ~30 kDa, respectfully. The dimer band intensity decreases as urea is increased and 
disappears at 2.5 M urea. For facile detection, we used in this experiment 0.20 mg/mL 
dPGM, which is 2-fold greater than the highest concentration we used in the equilibrium 
unfolding study. Still, it is obvious that the disappearance of the dimer band is 
coincidental with the first transition in the equilibrium unfolding of dPGM. This result 
confirms that the equilibrium intermediate is monomer. 
 
We also monitored the change in the hydrodynamic radius of 30 μg/mL dPGM by size-
exclusion chromatography under conditions favoring the native state (0 M urea) and the 
intermediate state (2.5 M urea) (Figure 2.3C). Without urea, one sharp peak is observed 
at an elution volume of 8.7 mL. In the presence of 2.5 M urea, one peak is observed at an 
elution volume of 9.5 mL. The change in the elution volume indicates that dPGM has a 
smaller radius at 2.5 M urea than at 0 M urea, suggesting that the intermediate is a 






than the peak at 0 M urea. Exchange between multiple conformations may cause the peak 
broadening observed at 2.5 M urea. The results of the concentration dependence of 
equilibrium unfolding, chemical cross-linking, and size exclusion experiments all support 
a monomer intermediate. With the oligomeric state determined, we use a three-state 
model with a monomer intermediate (Scheme 1) to analyze the equilibrium unfolding of 
dPGM. 
 
2.3.3 Effect of ATP on the thermodynamic stability of dPGM 
Using the model shown in Scheme 1, we quantified the effect of ATP on the equilibrium 
unfolding of dPGM (Figure 2.1 and Table 2.1). We fit globally the fluorescence 
monitored equilibrium unfolding data in the presence and absence of 1.0 mM ATP with 
the three-state model, despite the apparent two-state transition in equilibrium unfolding of 
dPGM in the presence of ATP. In the global fit, we reduced fitting parameters by sharing 
intermediate state and unfolded state signals, m-values, and the total protein 
concentration. In the absence of ATP, the free energy associated with the first transition 
(N2  2I; ΔGI-N°) and the second transition (I  U; ΔGU-I°) were determined to be 11.5 
± 0.1 kcal/mol and 6.6 ± 0.3 kcal/mol, respectively (Table 2.1). Independent curve fitting 
of the equilibrium unfolding of dPGM monitored by CD yielded similar values (Table 2.1 
and Figure 2.2). Note that the first transition is the unfolding of the dimer and that ΔGI-N° 
is the free energy change at the standard condition where both [N2] and [I] are 1 M. To 
get a better sense of the stability of the protein under our experimental condition (1.0 μM 
dPGM), we determined fN, fI, and fU using the equilibrium parameters from the curve-













  at a given protein concentration, is 
only 1.9 kcal/mol under native conditions; 1 in 25 monomeric units adopt non-native 
conformations (Figure 2.1B). 1.0 mM ATP increases ΔGI-N° by 7.0 ± 0.2 kcal/mol, which 
corresponds to an increase in stability of 3.5 kcal/mol per monomeric unit. The effect of 
1.0 mM ATP on ΔGU-I° was insignificant (0.6 kcal/mol). In the presence of 1.0 mM ATP, 
the effective stability of 1.0 μM dPGM is increased to 5.4 kcal/mol. The resulting effect 
of ATP is that only 1 in 8,600 monomeric units adopt non-native conformations under 
native conditions (Figure 2.1B). Further, in the absence of ATP, the intermediate reaches 
a maximum fraction of just over 0.94 around 2.5 M urea. In the presence of 1.0 mM ATP, 
the intermediate only reaches a maximum fraction of 0.12 around 3.7 M urea. ATP 
dramatically suppresses accumulation of the equilibrium intermediate. Therefore, our 
analysis strongly suggests that ATP selectively binds to the native dimer and not to the 
monomeric intermediate. 
 
The dependence of ΔGI-N° and ΔGU-I° on the urea concentration, mI-N and mU-I, 
respectfully, signifies that both transitions involve substantial unfolding. The m-value is 
proportional to the change in a protein’s solvent-accessible surface area during unfolding 
(Myers, Pace, & Scholtz, 1995). From the global fitting, we find that mI-N is 2.40 kcal 
mol-1M-1 and mU-I is 1.86 kcal mol
-1M-1. The total m-value for global unfolding, mU-N, is 
3.06 kcal mol-1M-1 per monomeric unit (mU-N = mI-N/2 + mU-I), which is in agreement with 
the m-value predicted for a dPGM monomer based on the number of residues (3.2 






monitored by CD produced similar m-values: mI-N of 2.3 kcal mol
-1M-1, mU-I of 1.80 kcal 
mol-1M-1, and mU-N of 2.95 kcal mol
-1M-1 (Table 2.1). Using PISA(Krissinel & Henrick, 
2007), we determined the area of the dimer interface in the crystallographic structure of 
dPGM (715 Å2 per monomer), and we predicted from the area that the m-value for dimer 
dissociation would be only 0.1 kcal mol-1M-1 per monomer. The fact that mI-N/2 (1.20 kcal 
mol-1M-1) is much greater than the value predicted for dimer dissociation suggests that 
the first transition involves not only dissociation of the dimer but also partial unfolding of 
the monomer. Further, mU-I (1.86 kcal mol
-1M-1) is much less than the predicted m-value 
for unfolding of the monomer (3.2 kcal mol-1M-1), which clearly shows that the second 
transition cannot account for unfolding of an intact monomer. The spectroscopic signal of 
the intermediate state is distinct from the native state by both fluorescence and CD which 
also supports a partially unfolded intermediate (Figures 2.1 and 2.2).  
 
2.3.4 Structural determinant of ATP binding to dPGM  
To elucidate the structural determinant of ATP for the interaction with dPGM, we 
monitored equilibrium unfolding of dPGM in the presence of 1.0 mM adenosine, AMP, 
ADP, or GTP (Figure 2.5A). While the effect of adenosine is negligible, AMP, ADP, and 
GTP significantly shift the first unfolding transition to higher urea concentrations. We fit 
globally the equilibrium unfolding data in Figure 2.5A, including equilibrium unfolding 
of dPGM in the absence and presence of 1.0 mM ATP, using the three-state model (Table 
2.2). The data sets in the global fitting share the same m-values and spectroscopic signals 
for native, intermediate, and unfolded states. AMP, ADP, and GTP all stabilize the native 






presence of the nucleotides. The change in ΔGI-N° (ΔΔGI-N°) is clearly dependent on the 
number of phosphate groups (Table 2.2); the more phosphate groups a nucleotide 
contains, the larger ΔGI-N° becomes. ATP and GTP have similar effects on dPGM, 
suggesting that the type of the nucleobase is not important in the interaction. The 
stabilizing effects of this series of nucleotides show that the phosphate groups of 
nucleotides are the primary structural determinant of the interaction with dPGM.  
 
The critical role of the phosphate groups in the interactions between nucleotides and 
dPGM led us to examine whether the same effect could be achieved by phosphate alone. 
We carried out equilibrium unfolding of dPGM in the presence of 50 mM phosphate or 
0.10 mM pyrophosphate (Figure 2.5B). Both salts dramatically stabilize dPGM, and the 
equilibrium unfolding appears two-state. We fit globally the equilibrium unfolding data 
in the presence of either phosphate or pyrophosphate in pair with the equilibrium 
unfolding data of dPGM without any ligand (Table 2.2). The stabilizing effects of both 
ions are similar in spite of the 500-fold difference in the concentration; 50 mM phosphate 
increased ΔGI-N° by 5.9 kcal/mol, and 0.1 mM pyrophosphate increased ΔGI-N° by 5.3 
kcal/mol. Again, increasing the number of phosphates per molecule drastically increases 
the stability conveyed to dPGM. Interestingly, 0.1 mM pyrophosphate is as effective as 
1.0 mM ADP in stabilizing dPGM, although pyrophosphate is present at a 10-fold lower 
concentration. The lack of the bulky nucleoside seems to enhance the binding affinity of 
pyrophosphate, which corroborates that the nucleoside group (nucleobase and ribose) 
does not have any significant role in the interaction. Rather, ATP and other nucleotides 






with an extensive array of cationic residues of the protein. The potential binding site with 
this property is the active site of dPGM. As the crystal structure of dPGM reveals, the 
active site contains many basic residues in close proximity (Bond et al., 2001). Moreover, 
the crystallographic structure of a complex between inactive dPGM and tetravanadate has 
shown that tetravanadate binds to the active site of the enzyme (Bond et al., 2002). 
Therefore, binding of the triphosphate groups of ATP to the active site may reduce 
unfavorable Coulombic interactions in the active site and stabilize the native form of 
dPGM. 
 
2.3.5 Prediction of the ATP-binding site by docking 
To predict the ATP-binding site in dPGM, we docked ATP to dPGM using Maestro for 
GLIDE docking (Friesner et al., 2004). The docking grid was larger than one dPGM 
monomer to refrain from biasing the predicted binding site. As illustrated in Figure 2.6, 
ATP was predicted to bind to dPGM within the active site. Bound ATP is oriented with 
the adenosine moiety partially exposed to solvent and docked in the active site opening 
while the phosphate groups are sheltered within the active site. We identified potential 
hydrogen bond partners as donor-accepter pairs separated by d and with acceptable 
geometry, where 2.5 Å ≤ d ≤ 3.3 Å. The adenine of ATP can only bond with Asn16 and 
the ribose forms one bond with Lys238.
 The phosphate groups of ATP are predicted to 
form ion-pair hydrogen bonds with multiple residues. The α phosphate group forms 
hydrogen bonds with Arg9, Lys99, Arg115, and Arg116. The β phosphate group forms 






furthest into the active site pocket, the γ phosphate group can form hydrogen bonds with 
Gly23 and Lys99.  
 
The predicted binding mode of ATP is analogous to the binding mode of the 
tetravanadate observed in the crystallographic structure of dPGM (Bond et al., 2002). 
Tetravanadate bound in the active site and the locations of the four vanadate groups were 
denoted as V1, V2, V3, and V4 (Bond et al., 2002). Remarkably, the α, β, and γ 
phosphates of ATP are predicted to be located approximately at V4, V3, and V2, 
respectively (Figure 2.6). Most of the predicted bonds between the phosphate groups of 
ATP and dPGM are also formed between tetravanadate and dPGM; only the α phosphate 
group is predicted to form bonds that are not observed with tetravanadate. This difference 
likely arises because three oxygen atoms of the vanadate moiety were modeled as zero 
occupancy due to poor electron density (Bond et al., 2002). The top four scoring poses 
from GLIDE were analyzed to test whether ATP is predicted to have multiple binding 
modes that are close in energy. Notably, the nucleoside moiety is predicted to adopt 
various conformations while the top two scoring poses show complete overlap in the 
positions of the phosphate groups (Figure 2.7). In the two less favorable poses, the α, β, 
and γ phosphates are located at V3, V2, and V1, respectively. The agreement between the 
predicted binding mode of ATP and that of tetravanadate in the crystallographic structure 







2.3.6 Contribution of the active-site residues to ATP binding and stability 
To test the involvement of active site residues in binding with ATP, we generated a series 
of dPGM variants with point mutation to alanine at Arg9, Lys99, Arg115, and Arg116 
(Figure 2.6). If a residue interacts with ATP through its side chain, an alanine mutation 
will abolish the interaction and result in ATP conferring less stability to that variant than 
to wild-type dPGM. As a control, we also mutated Lys222, which is distal to the active 
site (Figure 2.6), to alanine. CD spectra show that all the variants retain the secondary 
structure of wild-type dPGM (Figure 2.8). We examined the equilibrium unfolding of 
each variant in the presence and absence of 1.0 mM ATP (Figure 2.9). To quantify the 
changes in the stability conveyed to dPGM by ATP (ΔGATP°), we fit globally each variant 
in the presence and absence of 1.0 mM ATP using the three-state model represented in 
Scheme 1 (Table 2.3). Because ATP stabilizes only native dPGM, we define ΔGATP° as 
ΔGI-N(ATP)° - ΔGI-N°. 
 
As with wild-type dPGM, the equilibrium unfolding of each variant appears three-state. 
Effects of R9A and K222A mutations on equilibrium unfolding were insignificant 
(Figures 2.9A and 2.9E). However, K99A, R115A, and R116A mutations all shift the 
first transition to higher urea concentrations than observed with wild-type dPGM. This 
indicates that K99A, R115A, and R116A mutations stabilize the native state alone. K99A 
(Figure 2.9B), R115A (Figure 2.9C), and R116A (Figure 2.9D) mutations increase ΔGI-N° 
by 2.3± 0.2 kcal/mol, 3.1 ± 0.3 kcal/mol, and 1.2 ± 0.1 kcal/mol, respectively. No 






In the presence of 1.0 mM ATP, the stability of all variants is dramatically increased 
(Figure 2.9). For each active site variant, ΔGATP° is less than that of wild type (7.0 
kcal/mol). The R116A variant gains the most stability from ATP with a ΔGATP° of 5.4 ± 
0.2 kcal/mol. R9A and K99A are the least stabilized by 1.0 mM ATP with a ΔGATP° of 
4.2 ± 0.2 kcal/mol and 4.0 ± 0.4 kcal/mol, respectively. With R115A, ΔGATP° is 4.8 ± 0.4 
kcal/mol. Notably, the intermediate is still apparent for R9A in the presence of 1.0 mM 
ATP due to the rightward shift of its second unfolding transition. The control mutation, 
K222A does not appear to significantly influence the stabilizing effect of ATP (Figure 
2.9E). Because the active-site mutations reduce ΔGATP° while the control does not, ATP 
clearly interacts with the active-site residues. 
 
The effect of the active site mutations on native dPGM (N2) and the intermediate form (I) 
betray conformational differences between the two forms. If the environment of the 
mutated active site resides was similar in both N2 and I, then removal of the side chain 
would stabilize I similar to N2. The K99A, R115A, and R116A mutations stabilize N2, as 
evident by the increase in ΔGI-N°, but had insignificant effects on the second transition 
(Table 2.3). The selective enhancement of ΔGI-N° suggests that Lys99, Arg115, and 
Arg116 are in an unfavorable environment for N2 and that removal of the positive 
charges from the active site stabilizes the protein similar to phosphate binding. Because 
removal of Lys99, Arg115, or Arg116 does not alter the stability of I, the environment 
the residues experience in I is quite distinct from that in N2. Collectively, the effects of 
point mutations on the equilibrium unfolding of dPGM support a model where the active 






2.3.7 Validation of the ATP-interacting residues by isothermal titration calorimetry 
ATP binding by each dPGM variant was monitored using isothermal titration calorimetry 
(ITC) to obtain the dissociation equilibrium constant, Kd (Table 2.4). Wild-type dPGM 
was found to bind ATP with Kd of 0.32 ± 0.07 μM. R116A retained the greatest affinity 
for ATP out of the active site mutants with Kd of 1.5 ± 0.3 μM. The variants with the 
most jeopardized ATP binding are K99A and R115A, which have Kd of 7 ± 2 μM. For 
R9A, Kd is 5.5 ± 0.05 μM. As anticipated, K222A has a negligible impact on ATP 
binding with Kd of 0.4 ± 0.1 μM. The Kd value determined for each active-site mutant is 
increased relative to wild-type dPGM, which signifies the role of the residues in ATP 
binding. The effects of mutation on Kd confirm that each active-site residue chosen for 
mutation is involved in ATP binding while the control is not.  
 
From the Kd values, we calculated the free energy change for binding, ΔGbind°, at 1.0 mM 
ATP (Table 2.4). The effect of a mutation on ΔGbind° (ΔΔGbind°) should be the same as 
the effect of the mutation on ΔGATP° (ΔΔGATP°) determined from equilibrium unfolding 
if our model (Scheme 1) is correct. As shown in Table 2.4, the ΔΔGbind° and ΔΔGATP° 
values are similar for the active-site variants although ΔΔGbind° values are consistently 
greater in magnitude than the ΔΔGATP° values. This difference may arise from the effect 
of urea on ATP binding because we calculated ΔΔGATP° values from equilibrium 
unfolding in urea. Overall, the effect of the mutations as determined by ITC corroborates 
what we determined from the equilibrium unfolding study. The agreement between the 
two techniques also supports that the three-state model applied to equilibrium unfolding 







We demonstrated that equilibrium unfolding of dPGM occurs in a three-state manner 
with a monomeric intermediate (Figure 2.1A). The m-values and the spectroscopic 
signals indicate that the monomeric intermediate is partially unfolded. In the presence of 
ATP, the monomeric intermediate is barely populated throughout equilibrium unfolding 
(Figure 2.1B). By increasing ΔGI-N°, 1.0 mM ATP nearly shifts the equilibrium unfolding 
of dPGM into a two-state folding system where the entire protein is either folded or 
unfolded. Using a computational modeling and site-directed mutagenesis, we also clearly 
demonstrated that ATP binds to the active site of the enzyme through the interactions 
between cationic residues in the active site and the triphosphate group of ATP. During 
catalysis, the active site of dPGM accommodates the substrates (2-phosphoglycerate and 
3-phosphoglycerate) or the cofactor (2,3-bisphosphoglycerate). Apparently, the 
triphosphate group of ATP mimics the multianionic structures of the substrates and the 
cofactor. Though we identified dPGM as an ATP-binding protein in our previous 
proteomics screen, the interaction is not specific to ATP. Any ligand with repeating 
phosphate groups such as ADP, GTP, or pyrophosphate can bind to the active site with 
significant affinity. In this study, we investigated the binding of ATP to dPGM under a 
low salt condition to reliably assess the contribution of ligand binding to the folding of 
the protein. Because the interaction between ligands with phosphoryl groups and dPGM 
is mostly Coulombic, the affinity of the ligands to the protein is reduced under 
physiological salt conditions (Chapter 4). Still, the total concentration of the metabolites 
with diphosphate or triphosphate groups can be tens of millimolar in cellular environment, 






dPGM. Further studies would be necessary to elucidate the role of the interaction 
between the metabolites and dPGM under physiological conditions  
 
Ligand binding to dPGM selectively stabilizes the native dimer over a partially unfolded 
monomeric intermediate. Our analysis of equilibrium unfolding of dPGM in the presence 
of various ligands indicates that the ligands do not stabilize the monomeric intermediate; 
the effects of ligands on ΔGU-I° are all negligible (Tables 2.1 and 2.2). The lack of 
stabilization by the ligands suggests that the active site is disrupted in the monomeric 
intermediate. The effect of active-site mutations on stability also suggests that the active 
site is unfolded in the intermediate. Therefore, dissociation of the dimer into the 
monomeric intermediate also induces unfolding of the active site. The active site of 
dPGM is distal from the dimer interface (Figure 2.6); yet, proper folding of the active site 
and the dimer interface appears to be cooperative.  
 
A thermodynamic cycle clearly illustrates the cooperativity between ligand binding and 
dimerization in dPGM (Figure 2.10). In 2.5 M urea, where the cooperativity is most 
evident, dPGM is predominantly partially unfolded monomers (I) in the absence of ATP 
but ATP-bound dimers (N2•L2) in the presence of 1.0 mM ATP (Figure 2.1). The reaction 
from I to N2•L2 is thermodynamically favorable in the presence of 1.0 mM ATP. The free 
energy change associated with the reaction from I to N2•L2 in 2.5 M urea can be 
calculated using the thermodynamic parameters of equilibrium unfolding in Table 2.1 and 
Eq. 2 (ΔGN-I° = –12.5 kcal/mol). Under our experimental condition (1 μM dPGM), the 






of –2.4 kcal/mol per monomer, which is consistent with the reaction from I to N2•L2 
being thermodynamically favorable. The predominant presence of I in the absence of 
ATP indicates that dimerization of the partially unfolded monomer (I to N2) is 
thermodynamically unfavorable at 2.5 M urea. The free energy change associated with 
the reaction from I to N2 is again calculated using the thermodynamic parameters of 
equilibrium unfolding in Table 2.1 and Eq. 2 (ΔGN-I° = –5.5 kcal/mol). Under our 
experimental condition (1 μM dPGM), the effective free energy change(Park & Marqusee, 
2004a) of the reaction is 1.1 kcal/mol per monomer, which again confirms that folding of 
I to N2 is unfavorable under this condition. Then, the thermodynamic relationship shows 
that binding of ATP to the native dimer (N2) is associated with ΔG° of –3.5 kcal/mol in 
the presence of 1.0 mM ATP. The favorable binding energy by ATP (–3.5 kcal/mol per 
monomer) overcomes the unfavorable free energy associated with the folding and 
dimerization (1.1 kcal/mol per monomer). The affinity to ATP is enhanced significantly 
because the formation of N2 already pays the penalty of forming the binding-competent 
active site. This phenomenon is, therefore, an example of preorganization of the binding 
site. 
 
The energetics of the same reaction can be analyzed through the pathway with ligand-
bound folded monomer (M•L). As we cannot observe M•L under any circumstance, we 
do not have thermodynamic data for this pathway. However, the cooperative nature 
between ligand binding and dimerization can be explained with this pathway also. The 
dimerization of M•L to N2•L2 must be thermodynamically favorable, because the free 






of exposing the dimer interface to the solvent. Therefore, ligand binding drives the 
folding of the monomer (I to M•L), which is followed by a favorable dimerization 
reaction. This scenario can be seen as a cooperative binding between two ligands. 
Binding of one ligand (L) promotes the folding of the other binding site (the dimer 
interface), which dramatically increases the affinity for the other ligand (another 
monomeric unit).  
 
The ligand-induced dimerization of dPGM in 2.5 M urea is reminiscent of allostery 
observed in proteins with an intrinsically unstructured region. Maximal energetic 
coupling between two domains or regions is achieved when a segment of the protein is 
folded only in the presence of ligand and when abolishing the interaction between the 
domains causes a large energetic penalty (Hilser & Thompson, 2007; Wrabl et al., 2011). 
dPGM in 2.5 M urea satisfies these conditions. The active site and the dimer interface 
fold only when ATP or other stabilizing ligands are present. Also, exposing the dimer 
interface is significantly unfavorable. Also of note is that the energetic coupling in dPGM 
should enable ligand binding to one subunit to bolster the stability of the other subunit 
through the dimer interface, which will lead to favorable binding of ligand to the other 
subunit. Though the cooperativity is most dramatic in 2.5 M urea, the energetic coupling 
between the active site and the dimer interface exists under native conditions also. fI is 
significantly decreased in the presence of 1.0 mM ATP (Figure 2.1B). We expect that 
phosphorylation of His10 and/or substrate binding in one subunit will alleviate columbic 
strain in the active site and stabilize the dimeric form, which will lead to the stabilization 







The crystallographic structure of dPGM offers clues as to how the active site may be 
structurally coupled to the dimer interface. A loop comprising residues 118-151 leads 
from the active site of dPGM to the dimer interface with portions of the loop making 
intersubunit contacts (Figure 2.11). The loop connects helix α5 (residues 108-117), which 
forms part of the active site rim and contains Arg115 and Arg116, to helix α6 (residues 
152-167) (Figure 2.11). If the active site structure were disrupted, unfolding of helix α5 
may increase the dynamics of the adjacent loop; likewise, ligand binding to residues 
Arg115 and Arg116 could anchor helix α5 and reduce the dynamics of the adjacent loop 
and, consequently, stabilize the dimer interface. Interestingly, Arg115 interacts with the 
C-terminal tail of dPGM, which folds over the active site, when the enzyme is 
phosphorylated (Bond et al., 2001). Arg115 and Arg116 have been postulated to play a 
main role in switching between inactive and active conformations due to substrate 
binding (Bond et al., 2001). These two substrate-binding residues appear to be a hotspot 
for energetically linking the active site to structural change throughout the protein.  
 
The sequence, secondary structure, and active site structure of dPGM is well conserved 
across E. coli, S. cerevisiae, S. pombe, and human brain dPGM, with the key differences 
being localized to subunit interfaces (Bond et al., 2001). Despite the high sequence 
similarity between homologous dPGMs, E. coli and mammalian dPGMs are dimeric, S. 
cerevisiae dPGM is tetrameric, and S. pombe dPGM is monomeric (Bond et al., 2001). 
Like E. coli dPGM, oligomeric human and S. cerevisiae dPGMs have a “split” helix 






contacts (Rigden, Walter, Phillips, & Fothergill-Gilmore, 1999b; Yanli Wang et al., 
2005). However, the monomeric S. pombe dPGM contains a drastically truncated loop, 
25 residues shorter than the loop in E. coli dPGM, which would not be able to take part in 
the dimer interface (Figure 2.11) (J. Nairn et al., 1994; Uhrı́nová et al., 2001a). The 
absence of this long loop in the monomeric S. pombe dPGM suggests to us that the loop 
indeed provides a key structural link between the active site and subunit interface that 
drives the energetic coupling we observed. We are currently determining the structure of 
the monomeric intermediate of E. coli dPGM, which may elucidate the structural link 
between the active site and dimer interface. 
 
The energetic coupling between ligand binding and the dimerization in dPGM is 
consistent with the findings from computational studies that active-site residues tend to 
have greater energetic coupling with other regions of a protein (T. Liu et al., 2007; Luque 
& Freire, 2000). A survey of sixteen proteins revealed that active sites tend to contain 
low-stability regions which rearrange in the presence of ligand and underlie high affinity 
binding (Luque & Freire, 2000). When the active sites unfold, conformational changes 
tend to propagate throughout the protein, not simply in the vicinity of the active site 
(Luque & Freire, 2000). These low-stability active-site regions are then energetically 
linked with a significant portion of the protein structure (Hilser et al., 1998). A rigorous 
analysis of the energetic coupling between regions in the structures of five monomeric 
proteins revealed that active sites contain the residues with the greatest amount of 
energetic coupling to other regions of the protein; active sites exert the greatest control 







The effect of ATP and other stabilizing ligands on dPGM shows that cooperativity 
between ligand binding and dimerization may suppress dissociation of a dimer in the 
presence of ligand. This principle can be extended to multimeric proteins as well. In a 
multimeric protein, oligomerization can be energetically coupled with the folding of a 
distal active site and also ligand binding at the active site. The active site and the dimer 
interface of dPGM show positive cooperativity so that the two different regions fold and 
unfold in concert. The resulting effect of the positive cooperativity is that ligand binding 
stabilizes only the native multimeric forms and redistributes the ensemble populations 
away from partially unfolded monomeric forms. Increasing the energy gap between the 
native protein and partially unfolded conformations is paramount to avoiding risky partial 
unfolding, which can lead to proteolytic digestion (Hubbard, 1998), misfolding (Dobson, 
2003), aggregation (Horwich, 2002), and may cause disease states (Thomas, Qu, & 
Pedersen, 1995). In principle, negative cooperativity is also possible in multimeric 
proteins. In this case, ligand binding is coupled with unfolding of the interface, which 
promotes the dissociation of multimeric proteins. One seminal example of the negative 
cooperativity is the release of the two active monomers of protein kinase A from the 
heterotetrameric complex with two regulatory subunits upon binding of cAMP to the 
regulatory subunits (Taylor, Buechler, & Yonemoto, 1990) Exploiting and imitating 
energetic coupling between ligand binding and multimerization would be valuable in 
designing and engineering novel proteins not only with desired structures but also with 







2.5 Experimental Procedures 
2.5.1 Preparation of purified dPGM 
We overexpressed dPGM in E. coli BL21 (DE3)pLysS cells under the control of the T7 
promoter as described previously (Chang et al., 2012). After resuspending the harvested 
cells in 20 mM TrisHCl-NaOH buffer (pH 8.0) containing 10 mM EDTA, we lysed the 
cells by sonication. We collected the supernatant after centrifugation and sterilized the 
lysate via filtration with a 0.45 µm filter. We loaded the lysate into a DEAE-sepharose FF 
column (GE Healthcare Life Sciences; Piscataway, NJ) pre-equilibrated with 20 mM 
TrisHCl-NaOH buffer (pH 8.0). Bound proteins were eluted with a linear NaCl gradient 
from 0.10 M to 0.35 M. We then pooled the fractions containing dPGM and dialyzed 
overnight against 20 mM TrisHCl-NaOH buffer (pH 8.0). We further purified the 
dialyzed solution using a Source 15Q column on an ÄKTA FPLC system (GE Healthcare 
Life Sciences; Pittsburgh, PA). Bound protein was eluted with a linear NaCl gradient 
from 0 M to 0.25 M. We checked the purity of dPGM by SDS-PAGE. We concentrated 
the purified protein with a Centriprep 10K centrifugal filter (EMD Millipore; Billerica, 
MA) and determined the concentration of dPGM by absorbance at 280 nm using an 
extinction coefficient of 56,380 M-1 cm-1, which is estimated from the amino acid 
composition (Pace, Vajdos, Fee, Grimsley, & Gray, 1995). 
 
QuikChange site-directed mutagenesis kits (Agilent Technologies, Santa Clara, CA) were 
used to produce all dPGM variants. The sequence of each variant was verified at the 
Purdue Genomics Core Facility (West Lafayette, IN). All dPGM variants were purified 






2.5.2 Equilibrium unfolding and analysis 
We prepared 30 μg/mL dPGM (~ 1.0 μM) in 20 mM TrisHCl-NaOH buffer (pH 8.0) 
containing varying concentrations of urea (0 – 5 M). We investigated the equilibrium 
unfolding dPGM under a low ionic strength condition where the application of three-state 
model was most reliable and the effect of ATP was maximal (Data not shown). The 
absolute urea concentrations were determined from the refractive index (Pace, 1986). 
Additional ligands varied on an experimental basis. The samples were equilibrated 
overnight prior to spectroscopy. The unfolding of dPGM was monitored by intrinsic 
tryptophan fluorescence or circular dichroism (CD). Fluorescence emission spectra were 
collected from 320 nm to 400 nm with a FlouroMax-3 fluorimeter (Horiba Jobin Yvon; 
Edison, NJ) using an excitation wavelength of 280 nm. Changes in molar ellipticity were 
monitored at 222 nm with a JASCO J-815 CD Spectrometer (JASCO; Easton, MD).  
 
 
To analyze equilibrium unfolding by fluorescence, we first calculated the intensity-











where λ is the emission wavelength and I is the fluorescence intensity. Unlike the raw 
fluorescence intensity data, IWAW is not sensitive to variations in protein concentration 






to a three-state model with a monomer intermediate:(Gloss & Matthews, 1997; Mallam & 
Jackson, 2005) 
 
 K1 K2 
  
 Scheme 2.1 
 
The equilibrium constants are defined as: K1 = [I]
2/[N2] and K2 = [U]/[I]. By the linear 
extrapolation method (Greene & Pace, 1974), the dependence of the equilibrium 























where D is the urea concentration, ΔGI-N° is the free energy difference between N2 and 2I 
at 0 M urea, and ΔGU-I° is the free energy difference between U and I at 0 M urea. The 
mI-N and mU-I values are the dependence of ΔGI-N° and ΔGU-I°, respectively, on the urea 
concentration. The spectroscopic signal, Yo, is expressed as a summation of the 
contribution of each state:  
 







YN, YI, and YU are the spectroscopic signals of N2, I, and U, respectfully. fN, fI, and fU are 
the fractions of the monomeric unit in N2, I, and U, respectfully (fN + fI + fU = 1). We 
expressed fN, fI, and fU as functions of K1, K2, and Pt, the total protein concentration in the 
monomeric unit (Pt= 2[N2] + [I] + [U]), as described elsewhere (Mallam & Jackson, 
2005). We determined mI-N, mU-I, ΔGI-N°, and ΔGU-I° by fitting equilibrium unfolding 
data with eq 2.4 using OriginPro 8.5.1 (OriginLab; Northampton, MA). For global fitting 
of multiple equilibrium unfolding data sets, we reduced parameters by sharing the 
spectroscopic signals for the intermediate state and unfolded state, both m-values, and Pt 
amongst all data sets. For global fittings in Figure 2.5, the spectroscopic signals were 













where Y0 is the spectroscopic signal at a given urea concentration. 
 
When the stability of dPGM was determined in the presence of a ligand, we calculated 
the dissociation equilibrium constant Kd from the increase in the stability (ΔΔGunf°) using 


















where Kd is the dissociation equilibrium constant, and [L] is the ligand concentration.  
 
2.5.3 Chemical cross-linking 
To monitor dissociation of the dPGM dimer during equilibrium unfolding, we chemically 
cross-linked the dimer using bis(succinimidyl) penta(ethylene glycol) (BS(PEG)5) 
(Thermo Fisher Scientific; Waltham, MA) at varying concentrations of urea. We dialyzed 
a concentrated dPGM solution against 20 mM HEPES-HCl buffer (pH 8.0). Using the 
dialyzed dPGM solution, we prepared 0.20 mg/mL dPGM in 20 mM HEPES-HCl buffer 
(pH 8.0) with varying concentrations of urea (0 – 5 M). We initiated cross-linking by 
adding BS(PEG)5 to a final concentration of 2.0 mM. After incubating the reaction at 
25°C for one hour, we mixed 80 µL of each sample with 20 µL of 5-fold concentrated 
SDS-PAGE sample buffer. We analyzed the SDS-PAGE samples with a 15% 
polyacrylamide gel. After staining the SDS-PAGE gel with Sypro Red Protein Gel Stain 
(Life Technologies; Grand Island, NY), we imaged the gel with a Typhoon scanner (GE 
Healthcare Life Sciences; Pittsburgh, PA) and quantified the band intensities using 
ImageJ (http://imagej.nih.gov/ij). 
 
2.5.4 Size exclusion chromatography 
We conducted size exclusion chromatography using a TSKgel G3000SWxL column 
(TOSOH Bioscience LLC; King of Prussia, PA) with a column volume of about 14.3 mL. 
The mobile phase was 20 mM TrisHCl-NaOH buffer (pH 8.0) containing 50 mM NaCl 






each run, we injected 50 μL of dPGM solution into the column and ran at 0.5 mL/min 
while the absorbance at 280 nm was recorded. 
 
2.5.5 ATP Docking using GLIDE 
Docking of ATP to dPGM was carried out with the Maestro software suite (Schrödinger; 
New York, NY). The ATP ligand was prepared for docking using the LigPrep plugin 
included in Maestro. ATP was docked to inactive dPGM (PDB: 1E59) using GLIDE 
(grid-based ligand docking with energetics) docking (Friesner et al., 2004). For docking, 
the OPLS_2005 force field was used and ionization states for ATP were determined under 
pH 8.0 +/- 2.0 using Epik. A cubic docking grid was generated to fit the entire dPGM 
monomer so that the binding location was unbiased. Docking was performed using 
Glide's XP (extra precision) setting with the ligand treated flexibly. From the docking run 
the top 4 scoring ATP poses were retained. 
 
2.5.6 Circular dichroism 
CD spectra spanning 190 to 250 nm were collected on a JASCO J-815 CD spectrometer 
(JASCO, Easton, MD). dPGM samples were prepared from 10-fold dilutions of 
concentrated protein stock. The concentrations of dPGM were determined by absorbance 
at 280 nm. Samples were equilibrated at room temperature for at least two hours prior to 







2.5.7 Isothermal titration calorimetry 
All dPGM variants were prepared at 42 μM (1.2 mg/mL) and dialyzed against 20 mM 
TrisHCl-NaOH (pH 8.0) for ITC. After dialysis, the dPGM concentration was determined 
by absorbance at 280 nm. ATP (Sigma-Aldrich; St. Louis, MO) was prepared at a 
concentration of 0.40 mM in the dialysis buffer. To monitor ATP binding to dPGM, the 
heat evolution was monitored with A MicroCal iTC200 calorimeter (GE Healthcare Life 
Sciences; Pittsburgh, PA) upon ATP titration. ATP was titrated through 21 injections of 
0.40 mM ATP with 3-minute intervals. The resulting thermograms were automatically 
integrated by NITPIC (Keller et al., 2012) and fit with a model of 1:1 binding using 
SEDPHAT (https://sedfitsedphat.nibib.nih.gov) (Zhao, Piszczek, & Schuck, 2015). The 








Table 2.1 Thermodynamic parameters of dPGM in the presence and absence of ATP.  












0 11.5 ± 0.1 2.40 ± 0.06 6.6 ± 0.3 1.86 ± 0.09 24.7 ± 0.6 
1.0 18.5 ± 0.2 – 6.0 ± 0.4 – 30.5 ± 0.8 

























–a 11.6 ± 0.1 2.56 ± 0.03 5.6 ± 0.2 1.62 ± 0.05 – – 
Adenosinea 11.7 ± 0.1 – 5.6 ± 0.2 – 0.09 ± 0.07 – 
AMPa 13.6 ± 0.1 – 5.5 ± 0.2 – 1.96 ± 0.09 240 ± 40 
ADPa 16.4 ± 0.1 – 5.2 ± 0.2 – 4.8 ± 0.1 18 ± 3 
ATPa 19.3 ± 0.2 – 5.0 ± 0.3 – 7.7 ± 0.2 1.5 ± 0.5 
GTPa 20.9 ± 0.8 – 4.3 ± 0.6 – 9.3 ± 0.8 0.4 ± 0.5 
Phosphateb 17.3 ± 0.1 2.36 ± 0.03 5.6 ± 0.3 1.82 ± 0.08 5.9 ± 0.1 350 ± 60 
Pyrophosphatec 16.8 ± 0.1 2.47 ± 0.04 5.2 ± 0.3 1.62 ± 0.09 5.3 ± 0.1 1.2 ± 0.2 
aAll data sets were fit with one global fit; all ligand concentrations were 1.0 mM. 
bEquilibrium unfolding data with 50 mM Phosphate was fit globally along with equilibrium unfolding data without a ligand. 
cEquilibrium unfolding data with 0.10 mM Pyrophosphate was fit globally along with equilibrium unfolding data without a ligand. 
dΔΔGI−N° = ΔGI−N°(ligand) – ΔGI−N°(no ligand). 









Table 2.3 Thermodynamic parameters of dPGM variants in the presence and absence of ATP. 













0 12.4 ± 0.1 2.98 ± 0.07 6.4 ± 0.5 1.6 ± 0.1  
1.0 16.6 ± 0.2 – 6.3 ± 0.5 – 4.2 ± 0.2 
K99A 
0 13.8 ± 0.2 2.70 ± 0.08 7 ± 1 1.9 ± 0.3  
1.0 18.5 ± 0.2 – 6 ± 1 – 4.0 ± 0.4 
R115A 
0 14.6 ± 0.3 2.7 ± 0.1 5 ± 1 1.5 ± 0.3  
1.0 19.4 ± 0.3 – 5 ± 1 – 4.8 ± 0.4 
R116A 
0 12.71 ± 0.09 2.75 ± 0.05 6.0 ± 0.4 1.7 ± 0.1  
1.0 18.1 ± 0.2 – 5.8 ± 0.4 – 5.4 ± 0.2 
K222A 
0 11.6 ± 0.1 2.48 ± 0.09 6.1 ± 0.4 1.9 ± 0.1  
1.0 21 ± 2 – 4.4 ± 0.9 – 9 ± 2 





















WT 0.32 ± 0.07 4.7 ± 0.1 
  
R9A 5.5 ± 0.5 3.1 ± 0.05 –1.7 ± 0.1 –1.4 ± 0.1 
K99A 7 ± 2 2.9 ± 0.2 –1.8 ± 0.2 –1.5 ± 0.2 
R115A 7 ± 2 2.9 ± 0.2 –1.8 ± 0.2 –1.1 ± 0.2 
R116A 1.5 ± 0.3 3.8 ± 0.1 –0.9 ± 0.2 –0.8 ± 0.1 
K222A 0.4 ± 0.1 4.6 ± 0.1 –0.1 ± 0.2 1.2 ± 1 
aΔGbind° was calculated with Eq. 6 using [ATP] = 1.0 mM. 
bΔΔGbind° = ΔGbind°(varient) – ΔGbind°(WT) 











Figure 2.1 Effect of ATP on equilibrium unfolding of dPGM 
 (A) Equilibrium unfolding of 0.030 mg/mL dPGM was monitored by tryptophan 
fluorescence in the absence () and presence of 1.0 mM ATP (). (B) Populations of 
native, intermediate, and unfolded dPGM in equilibrium unfolding. The fraction of native 
(fN), intermediate (fI) and unfolded (fU) dPGM for 0.030 mg/mL dPGM in the presence 
(dashed line) and absence (solid line) of 1.0 mM ATP was calculated with the fitting 














Figure 2.2 Equilibrium unfolding of dPGM monitored by circular dichroism. 
Equilibrium unfolding of 0.030 mg/mL dPGM in varying concentration of urea was 
monitored by circular dichroism at 222 nm. Data were fit with Eq. 4 (solid line) and the 

















Figure 2.3 Oligomeric state of the equilibrium intermediate. 
(A) Equilibrium unfolding of dPGM at 0.01 mg/mL (), 0.03 mg/mL () and 0.10 
mg/mL () monitored by tryptophan fluorescence. Intensity-weighted average 
wavelengths (IWAW) were calculated from fluorescence emission spectra. (B) Chemical 
cross-linking of 0.20 mg/mL dPGM in the presence of 0 to 5 M urea. MW indicates the 
molecular weights of standard proteins in the protein ladder. (C) Elution profiles of 0.03 
mg/mL dPGM from size exclusion chromatography at 0 M urea (black) and 2.5 M urea 


























Figure 2.4 The concentration dependence of equilibrium unfolding of dPGM monitored 
by circular dichroism. 
Equilibrium unfolding of 0.020 mg/mL (), 0.030 mg/mL (), and 0.10 mg/mL (▼) 
dPGM was monitored by circular dichroism at 222 nm. The CD signal was normalized 











Figure 2.5 Effect of nucleotides on equilibrium unfolding of dPGM. 
(A) Equilibrium unfolding of 0.03 mg/mL dPGM was examined in buffer only () and 
in the presence of adenosine (), AMP (), ADP (), ATP (), and GTP () each at 
1.0 mM. The data were globally fit to Eq. 4 (solid lines), and the fitting results are shown 
in Table 2. (B) Equilibrium unfolding of dPGM was also monitored in the presence of 
0.050 M phosphate () and 0.1 mM pyrophosphate (). Both data sets and equilibrium 
unfolding data of dPGM without any ligand () were globally fit to Eq. 4 (solid lines), 
and the fitting results are shown in Table 2. The fitting results for dPGM unfolding in the 
presence of ATP is shown as a dashed line for reference. For proper comparison, 












Figure 2.6 Predicted binding mode for ATP. 
ATP was docked to dPGM (PDB entry 1E59) using GLIDE. ATP is shown docked in one 
active site in context of the full dPGM dimer. ATP is colored by element as follows: 
carbon (green), nitrogen (blue), phosphate (orange), oxygen (red). In the dimer structure, 
a chloride ion (green) is bound within the dimer interface. A magnified view of the active 
site reveals that the phosphates of ATP occupy the same positions as vanadate groups of 
the tetravanadate (light blue) that is bound in the crystallographic structure. The side 
chains are displayed for residues Arg9, Lys99, Arg115, and Arg116, which are predicted 
to hydrogen bond with ATP. The active-site histidine (His10) and Lys222 are also shown 













       
Figure 2.7 Comparison of the four most favorable poses of ATP docked to dPGM. 
The top scoring poses for GLIDE docking of ATP to dPGM (PDB: 1E59) are displayed 
from the most favorable to least favorable as green, yellow, orange, and red, respectively. 
The tetravanadate found in the dPGM crystal structure is shown as grey, and vanadate 






















Figure 2.8 CD spectra of the dPGM variants. 
The CD spectra of WT dPGM (black), R9A (orange), K99A (red), R115A (blue), R116A 









Figure 2.9 Effect of dPGM point mutations on the stabilizing effect of ATP. 
Equilibrium unfolding of 0.03 mg/mL (A) R9A, (B) K99A, (C) R115A, (D) R116A and 
(E) K222A in the presence () and absence () of 1.0 mM ATP. The fit lines of wild 














Figure 2.10 Mechanistic model for the energetic coupling of the dPGM active site and 
dimer interface 
A simple thermodynamic cycle (A) illustrates the energetic coupling in dPGM. Apo 
dPGM exchanges between the intermediate state (I) and the native state (N2). ATP binds 
to native dPGM (N2•L2) and reduces its free energy. If the dPGM active site was not 
energetically coupled to the interface, dPGM might form an ATP bound, folded monomer 
(M•L). The energetic penalty incurred for forming M•L ensures that dimerization and 














Figure 2.11 Putative structural link between the active site and the dimer interface. 
The cartoon diagram of the crystallographic structure of E. coli dPGM (PDB entry 1E59) 
is shown with a plausible structural link (red) between the active site and the dimer 
interface. A long loop leads from active site helix α5 to the dimer interface and then to 
helix α6. For comparison, the equivalent region was shown in the cartoon diagram of the 








CHAPTER 3. THE STRUCTURE OF A PARTIALLY UNFOLDED INTERMEDIATE 
OF E. COLI PHOSPHOGLYCERATE MUTASE 
3.1 Summary 
Previously, we determined that ligand binding to Escherichia coli cofactor-dependant 
phosphoglycerate mutase (dPGM), a homodimeric protein, is energetically coupled with 
dimerization. The equilibrium unfolding of dPGM revealed a stable, monomeric 
intermediate. Binding to several non-substrate metabolites stabilizes the dimeric native 
state over the monomeric intermediate, reducing the population of the intermediate. Both 
the active site and the dimer interface appear to be unfolded in the intermediate. We 
hypothesized that a loop containing residues 118−152 was responsible for the energetic 
coupling between the dimer interface and the distal active site and would be unfolded in 
the intermediate state. Here, we investigated the structure of the dPGM intermediate state 
by probing side-chain interactions and the peptide backbone. Equilibrium unfolding was 
used to assess the effect of truncating a side-chain on the stability of dPGM. By 
comparing the effect of a mutation on the global stability and the stability of the 
intermediate state, we determine an equilibrium φ-value to assess whether side-chain 
interactions are maintained or lost. Hydrogen/deuterium exchange coupled with mass 
spectrometry (HDX-MS) was used to investigate differences in the solvent exposure of 







equilibrium φ-value analysis and HDX-MS reveal the least stable folding unit of dPGM 
that is unfolded in the intermediate state and links the active site to the dimer interface. 
The structure of the intermediate reveals how the cooperative network of residues in 
dPGM gives rise to the observed allostery between dimerization and ligand binding.  
 
3.2 Introduction 
Proteins fold as a group of interacting cooperative subunits to form conformational 
ensembles. The conformations that these ensembles contain range between fully folded 
and globally unfolded, with populations that are determined by the free energy of each 
conformation (Dill & Chan, 1997; Frauenfelder et al., 1991; Hilser et al., 2006). Allostery 
is an integral feature of protein where two binding sites, distant to one another, are 
energetically coupled so that binding at one site affects binding at the other (Gunasekaran 
et al., 2004; Hilser et al., 2012). It has been argued that all dynamic protein are allosteric 
or contain allosteric sites (Gunasekaran et al., 2004). Allosteric coupling is crucial for 
many molecular processes such as protein signaling (Chennubhotla et al., 2008; Ernesto 
Freire, 1999; Harford & Weitzman, 1975; Hynes, 2002; Yu et al., 2010) and has been 
exploited for drug development (Berger et al., 1999; Carlson & McCammon, 2000; 
Kenakin, 2002). A wide range of allosteric responses have been successfully modeled by 
considering the effects of ligand binding on the protein ensemble (Hilser & Thompson, 
2007; Motlagh et al., 2014; Weber, 1972); binding at one site redistributes the 
conformational ensemble of the protein and shifts the population of conformations with 







the second ligand (Gunasekaran et al., 2004). The partitioning of protein into interacting, 
cooperative subunits is responsible for the allosteric effects on the conformational 
ensemble (Hilser & Thompson, 2007; Motlagh et al., 2014). Investigating the molecular 
basis of cooperativity and allostery within protein will better enable us to predict the 
effects of perturbations at a particular site in a protein on the conformational ensemble to 
accurately model, drug, and engineer proteins. 
 
The cooperative nature of protein folding arises from the energetic coupling between 
residues (Ernesto. Freire et al., 1992; Gunasekaran et al., 2004; T. Liu et al., 2007). The 
coupling shapes a protein’s energy landscape and causes the protein to fold as an 
assembly of individual cooperative units (Bai et al., 1995; Chamberlain et al., 1996; Hu et 
al., 2013). The energetic coupling between residues also enables allostery between distant 
sites. We previously found that the homodimeric protein Escherichia coli cofactor-
dependant phosphoglycerate mutase (dPGM) shows an allosteric response between 
dimerization and ligand binding at a distal active site (Chapter 2). We found that dPGM 
populated a partially unfolded, monomeric intermediate at low urea concentrations, but in 
the presence of several non-substrate metabolites, the protein populations shifted to the 
native dimer (Chapter 2). Folding of the active site is cooperative with the dimerization 
of dPGM. The cooperative network of residues that mediates signal transmission between 
the active site of dPGM and the interface appears to be responsible for both the folding 








Previously, dPGM was identified from a proteome-wide screen for ATP binding protein 
in the E. coli proteome (Chang et al., 2012). This result was intriguing because dPGMs 
do not use ATP for their catalysis. Phosphoglycerate mutase proteins primarily function 
as a mutase (EC 5.4.2.11) and interconvert 3-phosphoglycerate and 2-phosphoglycerate 
in a reaction that is driven by equilibrium concentrations of the substrate. dPGMs take 
part in glycolysis and gluconeogenesis and the isomerization reaction proceeds in 
opposite directions in each pathway. The cofactor dependency of dPGM arises from the 
need to phosphorylate an active site histidine in order to function as a mutase. In its 
inactive form, dPGM is a phosphatase (EC 3.1.3.13) and reacts with the cofactor 2,3-
bisphosphogylcerate to transfer a phosphate group to the active site histidine. An 
investigation into the effect of ATP on the energetics of dPGM revealed that some non-
substrate metabolites (like ATP) can drastically stabilize the native protein over a 
partially unfolded intermediate (Chapter 2). By selectively stabilizing native dPGM, 
metabolite binding reduces the populations of intermediate and increases the 
conformational cooperativity of dPGM.  
 
We hypothesized that a loop formed by residues 118-152, loop 118−152, that physically 
links the dPGM active site and dimer interface is the primary route of coupling between 
the two sites (Figure 2.11). Loop 118−152 is one of the least conserved regions amongst 
dPGM homologs that vary in quaternary structure between tetramer, dimer, and monomer 
(Bond et al., 2001). In the monomeric dPGM of Schizosaccharomyces pombe, the loop is 







the loop plays a critical role in oligomerization. If loop 118−152 is energetically coupled 
with the active site and dimer interface, then it should be unfolded in the intermediate 
state. Allosteric effects are maximized when a region of the protein is unfolded or 
extremely dynamic in the absence of a bound ligand (Goodey & Benkovic, 2008; Hilser 
& Thompson, 2007; Motlagh, Li, Thompson, & Hilser, 2012). Then, to understand the 
cooperative and allosteric network in dPGM we could investigate the structure of the 
intermediate state to determine the unfolded regions. Several factors often complicate the 
study of partially unfolded protein intermediates: transient formation, low populations at 
equilibrium, indistinguishable spectroscopic signals, and the presence of highly dynamic 
or unstructured regions (Campos et al., 2004). The dPGM intermediate is relatively stable 
and readily apparent by tryptophan fluorescence which makes dPGM an interesting 
system to investigate the structural features that underlie allostery and its role in 
oligomerization. 
 
Here, we test our hypothesis by elucidating structural differences between native dPGM 
and the partially unfolded, monomeric intermediate. The structural differences should 
reveal which regions of dPGM unfold and which remain folded in the intermediate state. 
By establishing which regions of dPGM fold upon dimerization we can assess how the 
structure of dPGM relates to the allostery between ligand binding and dimerization. To 
investigate the structure of the equilibrium intermediate of dPGM, we employ 
equilibrium φ-value (φeq) analysis (Campos et al., 2004; Sancho et al., 2002) and 







is similar to the traditional φ-value analysis, which was developed to probe the structure 
of transition states and kinetic intermediates (Fersht, Matouschek, & Serrano, 1992; 
Matouschek, Kellis, Serrano, Bycroft, & Fersht, 1990; Matouschek, Kellis, Serrano, & 
Fersht, 1989). Unlike traditional φ-value analysis, φeq-analysis uses only equilibrium 
information to quantify the effects of a mutation on the native state and intermediate state 
(Campos et al., 2004). By φeq-analysis we probe the side-chain contacts in the 
intermediate state and by HDX-MS we probe the solvent exposure of the peptide 
backbone. Our data reveal a cooperative folding unit that differentiates the native and 




3.3.1 Probing the structure the of the dPGM intermediate through point mutations 
To test our hypothesis that unfolding in the intermediate state was localized to loop 118-
152, we probed the side-chain contacts of native dPGM and the intermediate state using 
point mutations (Table 3.1, Figure 3.1). Most mutations were designed to remove only a 
portion of the side chain and should result in the loss or weakening of several interactions. 
From the effect of a mutation on the stability of the native state, ΔΔGU−N°, and the 
intermediate state, ΔΔGU−I°, we should be able to determine whether the mutated residue 
maintains its native side-chain contacts in the intermediate state (folded) or losses them 







mutation we will calculate the ratio between ΔΔGU−I° and ΔΔGU−N°, which is the 













  (3.1) 
 
where ΔΔGU−N° is the change in free energy between the native state and unfolded state 
per monomer due to a mutation. The φeq-analysis is analogous to traditional φ-value 
analysis, which reports on the side-chain contacts in transition states (Fersht et al., 1992; 
Matouschek et al., 1990; Matouschek et al., 1989). The interpretation of φeq and φ-values 
is alike; a value of 1 means the native side-chain contacts are maintained in the 
intermediate and a value of 0 means the side-chain contacts are lost in the intermediate 
(Campos et al., 2004; Matouschek et al., 1989). 
 
To obtain φeq-values, we perform equilibrium unfolding of the dPGM variants in order to 
accurately measure the stability of the native state and intermediate state. In 20 mM 
buffer only, dPGM populates the intermediate state at low urea concentrations. The 
mutations we made are designed to be destabilizing, which means the intermediate will 
be populated at lower urea concentrations that for wild-type dPGM and the native state 
may not be clearly discernible. To obtain the most robust thermodynamic parameters, the 
native state, intermediate state, and unfolded state should be well separated. Overlapping 







characterized the stabilizing effect NaCl on wild-type dPGM at concentrations of 0 M to 
0.5 M (Figure 4.5), and found that Cl- stabilizes the native state over the intermediate 
state. NaCl can be used to better differentiate the two states by increasing the free energy 
difference between them. We did not observe indications of structural change in wild-
type dPGM induced by NaCl (Chapter 4), so we will assume that NaCl will not alter the 
conformation of the dPGM variants. When the native state signal cannot be well resolved 
in the equilibrium unfolding of a dPGM variant, we will utilize NaCl to stabilize the 
native state and separate the native state and intermediate states signals. The dPGM 
variants will be compared with wild-type under the same salt condition.  
 
We generated nineteen dPGM variants with point mutations distributed throughout the 
protein (V8A, T22S, V27A, V34A, L43A, T56S, I63V, L66V, W67A, V80A, L86V, 
L94V, V111A, L125A, L147A, V160A, L169A, V191A, I235A) to probe most of the 
secondary structural units of dPGM (Table 3.1, Figure 3.1). The residue numbering and 
secondary structure assignment were determined by Bond, White, and Hunter (Bond et 
al., 2001). All assigned secondary structural units, ten α-helices, four 310-helices, and six 
strands of the core β-sheet, are involved in interactions with the residues that we chose 
for mutagenesis. Residues were determined to interact through Van der Waals 
interactions due to their proximity to one another (< 4 Å). Three mutations (I63V, W67A, 
and V80A) truncate side chains that interact with the opposing dPGM monomer. Trp67 
can also form a hydrogen bond with a Cl- buried within the dimer interface. Together, the 







3.3.2 Characterization of the fold of the dPGM variants 
All of the dPGM variants are able to form the secondary structure of the native state as 
determined by circular dichroism (CD) (Figure 3.2). Several dPGM variants were 
analyzed without added NaCl (V8A, T56S, L66V, and V80A dPGM), which reflects the 
variants under our least stabilizing condition (Figure 3.2A). Without salt, the CD spectra 
of the dPGM variants do not show any significant variance from wild-type dPGM. The 
remaining variants were analyzed under a more stabilizing condition with the presence of 
0.10 M NaCl (Figure 3.2B); as expected the dPGM variants have spectra similar to wild-
type dPGM in the presence of salt. Therefore, under the conditions we will investigate, 
the dPGM variants adopt the native secondary structure.   
 
Size exclusion chromatography with the dPGM variants revealed that the mutations did 
not significantly affect the hydrodynamic radius or oligomeric state of dPGM (Figure 
3.3). L86V and V111A dPGM were monitored without added salt, and they eluted at the 
same volume as wild-type dPGM (Figure 3.3A). The mobile phase contained 0.15 M 
NaCl for the other dPGM variants and the dPGM variants elute with similar volumes to 
wild-type. The average elution volume for all dPGM variants and wild-type dPGM in the 
presence of 0.15 M NaCl is 60.8 ± 0.9 mL. The small standard deviation of the average 
elution volume reflects the narrow distribution of elution volumes for the dPGM variants. 
No mutations appear to have disrupted dimer formation or substantially affected the 








3.3.3 Equilibrium unfolding of the dPGM variants 
For equilibrium unfolding analysis the dPGM variants are divided into two groups; the 
variants in Group 1 have a ΔΔGI−N° ≤ -0.8 kcal/mol in the presence of 0.10 M NaCl and 
the variants in Group 2 have a ΔΔGI−N° > -0.8 in the presence 0.10 M NaCl. The 
equilibrium unfolding of dPGM variants in Group 1 (V8A, V34A, L43A, T56S, I63V, 
L66V, V80A, L86V, V111A, V160A, V191A, and I235A dPGM) is analyzed in the 
presence of 0.10 M NaCl for φeq-analysis (Table 3.2, Figure 3.4). Due to the destabilizing 
nature of the mutations, addition of NaCl was necessary to resolve the native state (data 
not shown). The variants in Group 2 (T22S, V27A, W67A, L94V, L125A, and L147A 
dPGM) have large errors associated with their φeq-values due to uncertainty in ΔΔGU−I° 
(and ΔGU−I°) and the small magnitude of ΔΔGU−I°; changes in ΔGU−I° within the fitting 
error result in huge changes to the φeq-value for dPGM variants in Group 2. Also, the 
W67A, L125A, and L147A mutations reduced the stability of the native state so that the 
intermediate state is already partially populated at 0 M urea in the presence of 0.10 M 
NaCl and the spectroscopic signal of the native state is not clear (Figure 3.5). To obtain 
more robust φeq-values we needed to clearly resolve the signal of the native state and the 
intermediate state and obtain accurate thermodynamic parameters; obtaining more 
accurate thermodynamic parameters could be achieved by repeating equilibrium 
unfolding in triplicate at an ideal NaCl concentration, but the concentration is likely to 
vary for each dPGM variant. The concentration of NaCl also affects the resolution of the 
two equilibrium unfolding transitions of wild-type dPGM (Figure 4.5), our reference state 







transitions converge and the intermediate state becomes harder to discern. Because wild-
type dPGM is more stable than the dPGM variants, the optimal NaCl concentration to 
resolve the native state and the intermediate state for a given variant is likely to differ 
from wild-type dPGM.  For the dPGM variants in Group 2 and L169A dPGM of Group 1, 
we performed equilibrium unfolding under three difference NaCl concentrations and fit 
the data globally (Table 3.3, Figure 3.5). By varying the NaCl concentration we are able 
to incorporate conditions that resolve the native state and intermediate state well for both, 
the dPGM variant and wild-type dPGM.   
 
The equilibrium unfolding of the dPGM variants in Group 1 in the presence of 0.10 M 
NaCl proceeds via two unfolding transitions like wild-type dPGM (Figure 3.4, 3.5G). All 
the mutations except L169A and I235A shift the apparent midpoints of the two unfolding 
transitions, Cm1 and Cm2, to lower urea concentrations. L169A and I235A dPGM only 
show a reduced Cm2. To obtain thermodynamic parameters, we fit the equilibrium 
unfolding of each dPGM variant with eq 2.4 (Table 3.2, 3.3), which is derived from the 
three-state model shown scheme 1 in the experimental procedures. When fitting was 
performed, we assumed that the m-value for the global unfolding of dPGM is not affected 
by mutation, but is always equal to the value of wild-type dPGM (6.5 kcal mol-1 M-1). 
The m-value is the slope of the urea dependence of ΔG° and is proportional to the change 
in solvent exposed surface area upon folding or unfolding (Myers et al., 1995). Then, we 
make the assumption that the mutations did not significantly alter the amount of surface 







that most of the mutations in Group 1, V34A, L43A, T56S, I63V, L66V, V80A, V160A, 
V191A, I235A, have minimal effect on the free energy difference between native dPGM 
and the intermediate state, ΔGI−N°. The primary effect of the mutations is a reduction in 
free energy difference between the intermediate state and unfolded state, ΔGU−I°. Per 
monomer, the global stability (ΔGU−N°) of dPGM is (ΔGI−N°)/2 + ΔGU−I°. When ΔGI−N° 
is minimally affected by mutation, a reduction in ΔGU−I° affects ΔGU−N° almost equally. 
All the dPGM variants in Group 1 have a lower global stability than wild-type dPGM. 
The mutations in Group 1 destabilized both the native state and the intermediate state 
with respect to the globally unfolded state of dPGM.  
 
Several dPGM variants in Group 1 are outliers as they show a significant ΔΔGI−N°: V8A, 
L86V, V111A, and L169A dPGM. The effect of the L86V mutation was unique; L86V 
dPGM significantly reduced ΔGI−N° (ΔΔGI−N° = -1.43 kcal/mol). The intermediate state 
and native state are closest in energy for L86V dPGM, and L86V dPGM shows the 
lowest Cm1 value (Figure 3.4) out of the variants in Group 1. The L86V mutation reduces 
ΔGU−N° more than ΔGI−N°, which suggests that Val86 makes stronger interactions in the 
native state than the intermediate state. The V8A, V111A, and L169A mutations 
significantly increase ΔGI−N°, but they greatly reduce ΔGU−I° so that ΔGU−N° is still lower 
than for wild-type dPGM. Equilibrium unfolding of L169A dPGM (Figure 3.5G) appears 
to take place as one cooperative transition in the presence of 0.10 M NaCl. To separate 
the fluorescence signals of the intermediate state and the native state we investigated the 







As the salt concentration is reduced, the two unfolding transitions for L169A dPGM 
become apparent (Figure 3.5G). Global fitting of the L169A dPGM resulted in 
thermodynamic parameters with low uncertainties while a single fit for equilibrium 
unfolding of L169A dPGM in the presence of 0.10 M NaCl did not (data not shown). The 
case of L169A dPGM highlights the use of a range of NaCl concentrations.  
  
For each dPGM variant in Group 1, mI−N is greater than the value for wild-type (2.61 kcal 
mol-1 M-1) and mU−I is less than the value of wild-type (1.94 kcal mol
-1 M-1). Unfolding of 
the native state appears to expose more surface area for the dPGM variants than for wild-
type dPGM. The mutations may have caused further unfolding in the intermediate state. 
The large mI−N for V8A, L86V, V111A, and V160A dPGM (mI−N > 3.6 kcal mol
-1 M-1) 
strongly supports that these variants have a less folded intermediate state than wild-type 
dPGM. The smallest changes in m-values were observed with I235A dPGM, the variant 
with the smallest ΔΔGU−I° out of the Group 1 dPGM variants. If removing a side chain 
increases the amount of unfolding in the intermediate state, then the wild-type side chain 
must form important interactions and remain folded in the intermediate state. The m-
values of the dPGM variants in Group 1 suggest that the mutated residues remain folded 
in the intermediate state. 
 
The equilibrium unfolding of the dPGM variants in Group 2 (T22S, V27A, W67A, L94V, 
L125A, and L147A dPGM) was monitored at three different NaCl concentrations (Figure 







salt conditions. Notably, removal of a tryptophan from the W67A mutation shifted the 
fluorescence signal of native state from about 348 nm to 346 nm. For W67A, L125A, and 
L147A dPGM, the apparent Cm1 in the presence of 0.10 M NaCl is less than 1.0 M urea. 
The three variants partially populate the intermediate state at 0 M urea, which obscures 
the fluorescence signal of the native state. Higher NaCl concentrations were used to 
increase ΔGI−N° and resolve the native state signal of W67A, L125A, and L147A dPGM. 
Equilibrium unfolding of W67A, L125A, and L147A dPGM was conducted in the 
presence of 0.10 M, 0.20 M, and 0.50 M NaCl (Figure 3.5C, E, F). In the presence of 
0.10 M NaCl, T22S, V27A, and L94V dPGM have an apparent Cm1 of 1.5 M urea or 
greater. There was no need to better resolve the native state for these dPGM variants and 
so lower NaCl concentrations were used to better separate the unfolding transitions. The 
equilibrium unfolding of T22S, V27A, and L94V dPGM was monitored in the presence 
of 0.020 M, 0.050 M, and 0.10 M NaCl (Figure 3.5A, B, D). In contrast to Group 1, the 
dPGM variants in Group 2 tend to show no change in Cm2, only a reduced Cm1.  
 
Global fitting was performed on each variant to obtain the thermodynamic parameters 
(Table 3.3). L125A dPGM was consistently fit with a much lower mI−N than wild-type 
and when the global m-value is fixed at 6.5 kcal mol-1 M-1, mU−I and ΔGU−I° appeared to 
be overestimated. Equilibrium unfolding of L125A dPGM was fit globally without fixing 
any parameters (Table. 3.3, Figure 3.5E). Global fitting revealed that the dPGM variants 
in Group 2 all reduce ΔGI−N° by at least 1 kcal/mol and have small or insignificant effects 







greatest effect of the mutations in Group 2. The average ΔΔGI−N° for W67A, L125A, and 
L147A dPGM are -4.1 ± 0.2, -4.9 ± 0.1, and -3.6 ± 0.2 kcal/mol, respectfully; these 
mutations show a large destabilizing effect on the native state. The L125A mutation 
reduced ΔGI−N° more than any other mutation that we tested. For T22S, V27A, and L94V 
dPGM the average ΔΔGI−N° is -1.26 ± 0.06, -1.1 ± 0.2, and -2.1 ± 0.2 kcal/mol, 
respectfully. The T22S, V27A, and L94V mutations clearly destabilize the native state, 
but to a lesser degree than those probed by the W67A, L125A, and L147A mutations.  
 
The dPGM variants in Group 2 were fit with m-values similar to wild-type, except for the 
most destabilized dPGM variant: L125A dPGM. For L125A dPGM, mI−N is 1.97 ± 0.4 
kcal mol-1 M-1and mU−I is 2.05 ± 0.8 kcal mol
-1 M-1. While mU−I is not significantly 
affected by the mutation, the mI−N for L125A dPGM is about 25% lower than that of 
wild-type, suggesting that less surface is buried in the native conformation of L125A 
dPGM. The interactions made by Leu125 appear critical for the native form of dPGM but 
of little consequence to the intermediate. For T22S and L94V dPGM the m-values are the 
same as wild-type dPGM, within error. Collectively, the m-values support that the dPGM 
variants in Group 2 undergo a similar change in surface area upon unfolding as wild-type 
dPGM. Unlike the mutations in Group 1, the T22S, V27A, W67A, L94V, L125A, and 








3.3.4 φeq-value analysis 
With thermodynamic parameters determined for the dPGM variants, φeq-analysis was 
used to assess whether side-chain contacts are lost or maintained in the intermediate state. 
The φeq-value as defined in eq 3.1 is cast in terms of ΔΔGU−N°. Curve fitting returns 
values for ΔGI−N° and ΔGU−I° and in practice, φeq-values were calculated with ΔΔGI−N° 


















  (3.2) 
 
The φeq-values for the dPGM variants in Group 1 fall near 1.0 (Table 3.3, 3.4); φeq-values 
for the dPGM variants in Group 2 fall near 0 (Table 3.4). A φeq-value of 0 or 1 indicates 
the loss or preservation of side-chain contacts in the intermediate state, respectfully.  
 
Of the dPGM variants in Group 1, V8A, V34A, L43A, T56S, I63V, L66V, V80A, 
V160A, V191A, and I235A have φeq-values between 0.8 and 1.2. L86V dPGM is unique 
with a fractional φeq of 0.73 ± 0.09. V111A and L169A dPGM have φeq-values of 1.3 ± 
0.2 and 1.43 ± 0.02, respectfully. The low uncertainty for the φeq-value of L169A dPGM 
is achieved by averaging values from the global curve fitting (Table 3.3). The uncertainty 
in the φeq-value of I235A dPGM was the largest (± 0.5) and is a result of the mutation 
having a small effect on the stability of dPGM. In general, the uncertainty of the φeq-







V111A and L169A dPGM signify that the mutated residues convey more stability to the 
intermediate state than the native state. Val111 and Leu169 could form additional side-
chain contacts in the intermediate state which would explain the high φeq-values. The 
fractional φeq-value of L86V dPGM suggests either that a fraction of the native side-chain 
contacts are lost or that the residue experiences conformational heterogeneity in the 
intermediate state (Fersht et al., 1992). Leu86 makes van der Waals interactions with the 
peptide backbone of Tyr55 and Thr56 and interacts with Tyr163. T56S dPGM has a φeq-
value of 1.1 ± 0.2. Given the φeq-value, Thr56 appears to remain folded in the 
intermediate state and likely, Tyr55 as well. V160A dPGM makes van der Waals 
interactions with Lys85 and its φeq-value (0.9 ± 0.1) reveals that Val160 should be folded 
in intermediate state. Tyr163, which is located in the same α-helix as Val160, is also 
expected to be folded in the intermediate state. The secondary structural elements that 
Leu86 interacts with appear to remain folded in the intermediate state, but the 310-helix 1, 
containing Leu86, does lose contacts with the bound dPGM monomer in the intermediate 
state. The 310-helix may be more dynamic in the intermediate state of L86V dPGM than 
wild-type dPGM as a result. We think increased conformational heterogeneity accounts 
for the small deviation in the φeq-value of L86V dPGM from a value of 1. The φeq-values 
of all the dPGM variants in Group are near 1 and suggest that the mutated residues 
maintain side-chain contacts and remain folded in the intermediate state. 
 
The six dPGM variants in Group 2, T22S, V27A, W67A, L94V, L125A, and L147A 







of L125A dPGM is the most negative at -0.20 ± 0.05 and is less than 0 because the 
L125A mutation slightly enhanced ΔGU−I° while reducing global stability. However, the 
ΔΔGU−I° for L125A dPGM under different NaCl concentrations are not significantly 
different from 0. Despite the very large ΔΔGI−N° for L125A dPGM, the φeq-value is still 
sensitive to small changes in ΔGU−I° that fall within the uncertainty in ΔGU−I°. For 
proteins with intermediate states that are less discernible than the intermediate of dPGM, 
determining robust, low φeq-values by urea-induced equilibrium unfolding would be 
extremely challenging. The low φeq-values of the dPGM variants in Group 2 signify that 
side-chain contacts are lost in the intermediate state and suggest that the mutated residues 
are unfolded in the intermediate state. However, there are indications that Trp67 is not 
unfolded in the intermediate state despite its low φeq-value. W67A dPGM has the largest 
φeq-value (0.25 ± 0.02) of the dPGM variants in Group 2, indicative of the fact that the 
W67A mutation did reduce the stability of the intermediate state slightly. Analysis of 
Trp67 in the crystal structure of dPGM reveals that the side chain does make van der 
Waals interactions with Ile63 and His64 within the same α-helix (Table 3.1). I63V dPGM 
has a φeq-value of 0.9 ± 0.2 and L66V dPGM had a φeq-value of 1.0 ± 0.1; the high φeq-
values of these two dPGM variants supports that α-helix 3 is folded in the intermediate 
state and, consequently, Trp67 should maintain a portion of its side-chain contacts in the 
intermediate state. Still, Trp67 loses contacts that are formed between dPGM monomers 
and may lose the ability to form hydrogen bond with Cl- in the intermediate state which 
gives rise to the low φeq-value. Other than Trp67, the dPGM variants in Group 2 do 







Mapping the φeq-values of all the dPGM variants to the crystal structure of dPGM (Figure 
3.7A, B) clearly reveals a cluster of low φeq-values around loop 118−152 and a cluster of 
high φeq-values in the monomer core and along the dimer interface. In addition to loop 
118−152, loop 18−30 and loop 89−98 contain residues with φeq-values near 0. The loss of 
side-chain contacts indicated by the φeq-values suggests that these loops are unfolded in 
the intermediate state. Interestingly, W67A is the only mutation near the core of the 
dimer interface that resulted in a low φeq-value. Both I63V and V80A mutations resulted 
in the loss of interactions between dPGM monomers (Table 3.1) but still yield φeq-values 
near 1. Apparently helices 3 and strand C, which form the majority of the dimer interface, 
remain folded upon monomer dissociation. The β-sheet running through the dPGM core 
and α-helices 2, 4, 5, 6, 7, 8, and 10 all contain high φeq-value mutations and appear to be 
folded in the intermediate state. No mutations were made in Strands E and F, but the 
L43A, V191A, and I235A mutations all probed side chains that interact with the Strands 
(Table 3.1) and result in φeq-values near 1. The structure of dPGM reveals that 310-helix 1, 
in which Leu86 resides, is on the border between the loop region with low φeq-values and 
the core with high φeq-values (Figure 3.7A, B). The positioning of 310-helix 1 reveals that 
a significant portion of the interactions made by the 310-helix are formed with the loops 
that appear to be unstructured in intermediate state. The structural analysis supports the 
idea that conformational heterogeneity in the intermediate state gives rise to the fractional 
φeq-value of L86V dPGM. The view that arises from φeq-analysis is that unfolding in the 
intermediate state of dPGM is localized to one region that is formed by several 








In addition to probing side-chain interactions, we utilized hydrogen/deuterium exchange 
coupled with mass spectrometry (HDX-MS) to monitor changes in the peptide back bone 
of dPGM in the intermediate state at the peptide level. Peptides that report little exchange 
are protected from solvent and should be folded while a large amount of exchange 
indicates unfolding. Samples of wild-type dPGM were prepared under conditions to 
maximize the population of the native state, intermediate state, or the unfolded state. 
With native dPGM, HDX-MS was conducted in the presence and absence (data not 
shown) of 1.0 mM ATP; we detected little difference in deuterium uptake between the 
two conditions and used dPGM in the presence of ATP as the condition to maximize the 
population of the native state. Each state of the protein was placed in a deuterated buffer 
to allow deuterium exchange for two minutes. Samples were quenched by addition of 
quench buffer and flash freezing them with liquid nitrogen. Quenched samples were 
thawed and immediately analyzed using LC/MS with online pepsin digestion to obtain 
high-resolution information at the peptide level. The deuterium incorporation was 
quantified from differences in peptide mass relative to an undeuterated control (Figure 
3.6). The peptides we analyzed were found in all samples and cover 93% of the protein 
sequence. HDX-MS was repeated in triplicate for dPGM in each state and the resulting % 









The mean % deuterium uptake of dPGM in the native, intermediate, and unfolded state is 
much lower for the native state in the majority of the peptides (Figure 3.6A). The 
unfolded state samples show deuterium incorporation that is greater than or equal to the 
native state and intermediate state samples for all peptides. Overall, the mean % 
deuterium uptake is greatest near the C-terminus for dPGM in each state. Peptide 
114−125, a portion of loop 118−152, and peptides 199−203 and 235−249 show high 
deuterium uptake in all three states of dPGM. This suggests that the residues covered by 
these peptides are located in dynamic regions in all states of dPGM. To better analyze the 
differences between the native and intermediate states we calculated the relative 












%   (3.3) 
 
where %Dx is the mean % deuterium uptake of a peptide from state x and %DU is the 
mean % deuterium uptake of the peptide from the unfolded state. An f%D of 1 signifies 
deuterium uptake equal to the unfolded state and a value of 0 would signify no relative 
uptake. Several peptides from the intermediate state of dPGM show protection from 
deuterium exchange with a relative uptake of less than 0.6: peptides 1−7, 169−186, 
188−197, and 203−216. Peptide 216−233 also shows some protection with an f%D of 0.66. 







unfolded state. The corresponding secondary structural units that show some protection 
from HDX in the intermediate are α-helices 1 and 8 and strands A, D, E, and F. The 
protected residues are predominantly in the dPGM core. The remaining peptides from the 
intermediate state show a high f%D. In the native state, several peptides are highly 
protected from HDX and have an f%D of less than 0.25: peptides 30−52, 53−67, 70−77, 
71−94, 147−163, 169−186, and 188−197. Another group of peptides from the native state 
has an f%D between 0.25 and 0.50 (peptides 1−7, 91−113, 126−142, and 203−216). The 
peptides from the native state showing a high deuterium uptake with an f%D greater than 
0.5 are peptides 6−24, 114−125, 216−233, 199−203, and 235−249.  
 
Several peptides show a large change in the relative deuterium uptake (Δf%D) between the 
native state and the intermediate state, Δf%D = f%D(native) − f%D(intermediate). A large 
Δf%D suggests that the residues covered by the peptide experience much different solvent 
exposure in the intermediate state than in the native state. Residues that are unfolded in 
the intermediate state are expected to fall within a peptide showing a large Δf%D. The 
largest Δf%D observed is -0.81 for peptide 53−67. For the six peptides spanning residues 
30 to 113 and peptides 126−142 and147−163 the value of Δf%D is greater in magnitude 
than 0.55; all of the peptides showing a large difference in Δf%D also show a dramatically 
lower mean % deuterium uptake for the native state than for the intermediate and 
unfolded states. With the exception of peptide 114−125, which shows high deuterium 








To understand the structural differences between the native state and intermediate state of 
dPGM that are captured by HDX-MS, the Δf%D values are mapped to the dPGM crystal 
structure as shown in Figure 3.7C and D. The peptides with a large Δf%D are localized to 
the dimer interface (α-helices 2 and 3, strand C), the active site (α-helices 4 and 5), loops 
89−98 and 118−152, α-helix 6. A portion of loop 118−152 covered by peptide 114−125 
has a low Δf%D due to the fact that deuterium uptake by peptide 114−125 was high for all 
states of dPGM. The secondary structures covered by peptides with a large Δf%D and 
peptide 114−125 form a large, continuous region of dPGM that is either unfolded in the 
intermediate state or experiences a large change in solvent exposure upon dissociation. 
Our φeq-analysis corroborates that loops 89−98 and 118−152 are unfolded in the 
intermediate state. Most of the region covered by peptides with a large Δf%D was found to 
retain side-chain contacts in the intermediate state (α-helices 2, 3, 4, 5, and 6, loop 83−88, 
strand C), suggesting that the region is not unfolded. The secondary structural units 
involved most likely undergo a large change in solvent exposure or dynamics upon 
transitioning the intermediate state. The core of the dPGM monomer containing the 
majority of the β-sheet and α-helices 1, 8, 9, and 10 shows low Δf%D-values, which 




Through use of φeq-analysis and HDX-MS we describe a low resolution structure of the 







structure can be grouped into three discrete regions. One region contains the secondary 
structural features that appear unfolded in the intermediate state and is the least stable 
folding unit of dPGM (red in Figure 3.8). The other two regions both appear folded in the 
intermediate state, but one shows a large Δf%D (orange in Figure 3.8) due to changes in 
solvent exposure while the other shows a low Δf%D (gray in Figure 3.8). We have 
previously found that the active site of dPGM is energetically coupled with the dimer 
interface and both appear to be disrupted in the intermediate state (Chapter 2). We 
hypothesized that loop 118−152 was responsible for linking the active site and dimer 
interface and would unfold in the transition from the native state to the intermediate state. 
Here, we showed that loop 118−152 in addition to two other intervening loops link the 
active site and dimer interface through a network of tertiary interactions. Three loops 
(loop 19−29, 88−98, and 118−152) and three α-helices (α-helix 1, 4, and 5) form the least 
stable, cooperative folding unit of dPGM. Interactions between these secondary structural 
features physically and energetically link the active site (α-helices 4 and 5) and dimer 
interface such that a portion of each will fold and unfold in unison. The energetic 
linkages between the residues involved in the least stable folding unit underscore the 
allostery observed between ligand binding and dimerization of dPGM (Chapter 2). 
 
In contrast to the dPGM core, the least stable cooperative folding unit is primarily 
composed of loops. Our data suggest that three α-helices (helices 1, 4, and 5) are 
involved in the folding unit but are not fully unfolded in the intermediate state; the 







retaining helical structure. Many factors suggest α-helix 4 and 5 lose interactions with 
other secondary structural units in the intermediate state. The two helices form many 
interactions with the three loops that unfold in the intermediate state and only helix 5 
forms a few interactions with helices 8 and 9 of the dPGM core. HDX results showed that 
α-helices 4 and 5 are only protected from deuterium exchange in the native state. Residue 
Lys99 of α-helix 4 and residues Arg115 and Arg116 of α-helix 5 were previously 
investigated by mutagenesis (Chapter 2); the three residues are involved in ligand binding 
and appear to be unfolded in the intermediate state (Chapter 2). However, α-helices 4 and 
5 interact with one another significantly to form the kinked active site rim (Figure 3.8). 
Val111 seems to form important contacts between α-helices 4 and 5 in the intermediate 
state as removal of the side chain appears to promote further unfolding in the 
intermediate state (Table 3.1, 3.2). Together, the results suggest that α-helices 4 and 5 no 
longer form part of the active site rim and may be dynamic in the intermediate state, but 
the two helices remain in contact with one another. The residues in α-helix 1 interact with 
one another and with loops 19−29, and 89−98, which are both unfolded in the 
intermediate state. Both Thr22 and Val27 interact with α-helix 1 (residues 13-19) and 
both residues lose their native contacts in the intermediate state. Peptide 6−24 includes α-
helix 1 and it shows low deuterium incorporation even in the unfolded state (Figure 3.6A). 
Similar to α-helices 4 and 5, α-helix 1 likely becomes dynamic due to the unfolding of 
adjacent loops but the helix appears to remain structured due to internal interactions. 







Leyrat et al., 2011; Yi Wang & Shortle, 1997). Full unfolding appears restricted to the 
network of loops in the least stable folding unit, which we term the loop region.  
 
Our results suggest that the folded portion of the dPGM intermediate is comprised of two 
regions with distinct properties (Figure 3.7). The first folded region has a small Δf%D and 
forms the core of the dPGM monomer and we refer to it as the stable core. The stable 
core contains strands A, D, E, and F as well as α-helices 8, 9, and 10. His10, the site of 
phosphorylation by the cofactor of dPGM, is also included in the stable core. Previously, 
we characterized R9A and K222A dPGM, both of which contain a point mutation in the 
stable core (Chapter 2). The equilibrium unfolding of both variants occurs with the 
transition from the native state to the intermediate state coincident with wild-type. While 
other mutations that remove a positive charge from the active site significantly shift the 
first unfolding transition to higher urea concentrations, R9A does not (Chapter 2). 
Investigation of R9A and K222A dPGM support that the core and a portion of the active 
site remain folded in the intermediate state. The second folded region, which shows a 
large Δf%D, we denote as the interface region, because most of the secondary structural 
units in this region form the dimer interface (α-helix 3, strand C, 310-helix 1) or make 
extensive interactions with the structural units that form the interface (α-helix 2 and 7, 
strand B). The last secondary structural unit included in the interface region is α-helix 6, 
which interacts with loop 118−152. The large f%D of the interface region in the 
intermediate state can be explained by the increased solvent exposure upon dimer 







many lost interactions. So long as native side-chain contacts are maintained in the 
majority of the intermediate state conformational ensemble, our φeq-analysis will not 
report on the region’s altered dynamics. The stable core of the dPGM intermediate and 
the exposed interface region may be discrete folding units as colored in Figure 3.7, 
though we did not directly observe separate folding of the two. 
 
The structure of the dPGM intermediate and partitioning of dPGM into interacting 
folding units (Figure 3.9) clarifies the energetic coupling and allostery between ligand 
binding and dimerization of dPGM. Recall that allostery occurs when a protein contains 
two distal binding sites and binding of ligand at one site influences the binding of the 
second ligand at the distal binding site (Gunasekaran et al., 2004; Hilser et al., 2012). In 
the case of dPGM, one binding site is the dimer interface formed by the loop region and 
the interface region, and the ligand is another dPGM monomer; the second binding site is 
the dPGM active site formed by the loop region and the stable core. Many anions appear 
able to bind at the active site (Chapter 2, Chapter 4). Protein active sites tend to be split 
into regions of high and low structural stability with the catalytic machinery located in 
the high stability region and most of the substrate binding residues located in the low 
stability region (Ernesto Freire, 1999; Luque & Freire, 2000). The presence of a dynamic, 
low stability region is thought to enable allostery and transmit information between the 
active site and other regions of the protein via conformational change (Ernesto Freire, 
1999; T. Liu et al., 2007). Both the dimer interface of dPGM and the active site clearly 







dimer interface of dPGM is responsible for recognition and initial binding between the 
two dPGM monomers because most of the binding site is preformed. Preformed structure 
facilitates the binding of intrinsically disordered protein before folding to the final bound 
form occurs (Fuxreiter, Simon, Friedrich, & Tompa, 2004; Knott & Best, 2012); 
preformed secondary structural units interact in a high-energy transition state and drive 
folding to the low-energy bound form (Daggett & Fersht, 2003; Fuxreiter et al., 2004; 
Zitzewitz, Ibarra-Molero, Fishel, Terry, & Robert Matthews, 2000). Interaction between 
the interface regions of two dPGM monomers likely occurs in a transition state followed 
by folding of the loop regions. Folding of the loop region completes the dimer interface 
and propagates information about the dimerization event throughout the loop region and 
active site. The dPGM active site contains most of the catalytic machinery (Bond et al., 
2002), residues Arg9, His10, Arg61, and His183, in the stable core while two residues 
involved in catalysis, Asn16 and Glu88, as well as substrate binding residues, Thr22, 
Gly23, Arg89, Tyr91, Lys99, Arg115, and Arg116, are located in the dynamic loop 
region. The intermediate state of dPGM has a partially formed active site but most 
substrate binding residues are only found to be folded in the native dimer. Dimerization 
of dPGM will radically enhance ligand binding affinities due to the folding of the loop 
region. Conversely, if the preformed active site of the intermediate state can interact with 
a ligand through a high-energy transition state, it will facilitate folding of the remaining 
portion of the active site and the loop region. Then, encountering a ligand in the 
intermediate state will result in enhanced dimerization. The dynamic loop region of 







in which one ligand is the protein itself, is an interesting case in which the function 
appears to be an enhancement of conformational stability rather than relaying a signal. 
However, the energetic coupling between the active site and dimer interface should 
energetically couple the active sites of both bound dPGM monomers. Binding events or 
phosphorylation at one active site may have an effect on binding and phosphorylation at 
the second active site.  
 
The partitioning of dPGM into rather independent folding units enables the protein to 
have a stable core while also maintaining a large relevant stability, (ΔGI−N°). The relevant 
stability of a protein is the energy gap between the native protein and the lowest energy 
non-functional intermediate (Sancho et al., 2002). This energy gap is the most relevant to 
retain native, active protein because the intermediate is the most probable non-native 
conformation to be sampled. The core of dPGM is stable enough to form an intermediate 
and any stabilization of the core should stabilize the intermediate state and native state. 
Although the loop region is critical for ligand binding and dimerization of dPGM, it does 
not appear to be significantly coupled with the stable core. The tendency of the φeq-values 
for dPGM to fall near 0 or 1 supports the idea that the dPGM core is not significantly 
coupled with the loop region. The structure of an equilibrium intermediate of Anabaena 
apoflavodoxin was also determined through extensive φeq-analysis. Of our twenty dPGM 
variants, the φeq-values for seventeen variants fall within 0.3 of 0 or 1; for apoflavodoxin, 
only four out of eighteen of the determined φeq-values fall within 0.3 of 0 or 1 (Campos et 







intermediate appeared to arise from the weakening of side-chain interactions throughout 
the core relative to the native state (Campos et al., 2004). The weakened bonds 
throughout the core of the apoflavodoxin intermediate reveal that the unfolded region of 
the intermediate is coupled with the folded region and folding of both is required for full 
strength interactions. The tendency of high φeq-values for dPGM to fall near 1 reveals that 
the side-chain contacts in the folded region of the dPGM intermediate are as favorable as 
in the native state; the side-chain interactions are not significantly affected by unfolding 
of the loop region. In contrast to apoflavodoxin, the folded core of the dPGM 
intermediate appears to function as an independent folding unit. Apoflavodoxin was 
rationally engineered to exhibit cooperative, two-state unfolding by enhancing the 
stability of the least stable folding unit (Lamazares, Clemente, Bueno, Velázquez-
Campoy, & Sancho, 2015). The independence of the dPGM core allows ligand binding to 
only enhance the relevant stability (ΔGI−N°) and increase the folding cooperativity of 
dPGM analogous to the engineering efforts with Apoflavodoxin.   
 
The cooperative network and allostery observed with dPGM enables the protein to 
greatly increase the stability of the native form over a partially unfolded intermediate by 
binding metabolites (Chapter 2) or salts (Chapter 4) that are prevalent in the cellular 
environment. The low stability of the loop region and high deuterium uptake imply that 
the region is dynamic. The cooperative network and allosteric response are also likely to 
be intimately coupled with the dynamics of the loop region (Chennubhotla et al., 2008; 







dimer, monomer) and show the greatest sequence divergence in the loop region (Bond et 
al., 2001). The pivotal role of the loop region on the energetics and allosteric behavior of 
E. coli dPGM suggest that this divergent region is fine tuned for the proper behavior of 
each dPGM in its physiological milieu. The dPGM of Saccharomyces cerevisiae is a 
tetramer and may access an active dimeric and even monomeric intermediate (Hermann, 
Jaenicke, & Price, 1985; White, Fothergill-Gilmore, Kelly, & Price, 1993a). An active 
site mutation, H181A, causes of S. cerevisiae to dissociate into dimers upon cofactor 
binding, showing negative cooperativity (White, Fothergill-Gilmore, Kelly, & Price, 
1993b). The link between ligand binding and oligomerization appears much different for 
S. cerevisiae dPGM than for E. coli dPGM. Allosteric behavior and cooperative networks 
have been found to be conserved amongst homologous proteins in some cases (Law, 
Fuentes, & Lee, 2009; Suel, Lockless, Wall, & Ranganathan, 2003; Wrabl et al., 2011) 
and to be divergent in other cases (Coyle, Flores, & Lim, 2013; Kuriyan & Eisenberg, 
2007; Morra, Genoni, & Colombo, 2014). Colocalization of proteins may greatly 
facilitate the evolution of allosteric behavior and lead to differences in behavior for 
homologous protein with essentially the same structure (Kuriyan & Eisenberg, 2007). An 
investigation into the cooperative network and allosteric behavior of dPGM homologs 
may reveal how divergence in the loop region regulates the cooperative network and 








3.5 Experimental Procedures 
3.5.1 Protein expression and purification 
E. coli BL21 (DE3) PLysS cells were used to over-express dPGM as previously 
described (Chapter 2). All dPGM variants were constructed with QuikChange site-
directed mutagenesis kits (Agilent Technologies, Santa Clara, CA) and plasmids were 
sequenced at the Purdue Genomics Core Facility (West Lafayette, IN) to confirm that the 
mutations were made. BL21 cells were lysed by sonication and all dPGM variants were 
purified through two rounds of anion exchange chromatography (Chapter 2). Purified 
dPGM was concentrated with the Centriprep 10K filter (EMD Millipore, Billerica, MA) 
and stored at 4°C or -80°C for prolonged storage. The purity of each dPGM variant was 
determined to be greater than 95% by analysis of SDS-PAGE gels with Coomassie blue 
staining. The final concentration of each dPGM variant was determined by absorbance at 
280 nm using an extinction coefficient estimated from the amino acid composition (Pace 
et al., 1995). 
 
3.5.2 Circular dichroism 
CD spectra spanning 200 to 250 nm were collected on a JASCO J-815 CD spectrometer 
(JASCO, Easton, MD) for all dPGM variants. 0.30 mg/mL dPGM samples were prepared 
from 10-fold dilutions of the protein stock into 20 mM TrisHCl−NaOH (pH 8.0) with or 
without 0.10 M NaCl as shown in Figure 3.2. The concentrations of dPGM in the 10-fold 
dilutions were determined by absorbance at 280 nm and were used to calculate the dPGM 







least two hours prior to spectroscopy. The CD signal of the buffer was subtracted before 
the raw CD signal of the dPGM variants was converted into mean-residue molar 
ellipticity.  
    
3.5.3 Size exclusion chromatography 
A HiLoad 16/600 Superdex 75 pg column (GE Healthcare Life Sciences; Piscataway, NJ) 
was used to perform size exclusion chromatography with each dPGM variant. The mobile 
phase was 20 mM TrisHCl−NaOH buffer (pH 8.0) alone (Figure 3.3A) or buffer with 
0.15 M NaCl (Figure 3.3B,C,D). We prepared 1.0 mg/mL dPGM in the respective mobile 
phase and injected 1.0 mL of the sample for each run. Size exclusion was conducted with 
a flow rate 1.6 mL/min while the absorbance at 280 nm was recorded. 
 
3.5.4 Equilibrium unfolding 
The urea-induced equilibrium unfolding of dPGM was monitored by intrinsic tryptophan 
fluorescence. For all experiments, 0.030 mg/mL dPGM was prepared in 20 mM 
TrisHCl−NaOH buffer (pH 8.0) containing varying concentrations of urea (0 – 5 M) and 
NaCl. The urea concentrations were determined from the refractive index of a stock 
solution (Pace, 1986). The equilibrium unfolding samples were equilibrated at room 
temperature overnight prior to spectroscopy. Fluorescence emission spectra spanning 320 
to 400 nm were collected with a FlouroMax-3 fluorimeter (Horiba Jobin Yvon; Edison 
New Jersey, NJ) using an excitation wavelength of 280 nm. During data collection, the 







The equilibrium unfolding data is analyzed as intensity-weighted average wavelength 
(IWAW) as previously described (Chapter 2). The data was fit with a three-state model 





Curve fitting was carried out as previously described using OriginPro 8.5.1 (OriginLab; 
Northampton, MA) with eq 2.4 to determine the m-values and the free energy differences 
between states, ΔGI−N°and ΔGU−I° (Chapter 2). However, for all dPGM variants except 
L125A dPGM, the global m-value was fixed at the value of wild-type dPGM (6.5 kcal 
mol-1 M-1) determined from a global fitting of wild-type dPGM in the presence of 0 to 
0.50 M NaCl (Chapter 4). The global m-value was fixed by defining mU-I as (6.5 – 
mI−N)/2 in eq 2.3. For global fits, the fluorescence signal of the native state and 
intermediate state, the dPGM concentration, and mI−N are shared amongst all data sets. 
The φeq-values, as defined by eq 3.1 (Campos et al., 2004; Sancho et al., 2002), were 
calculated from the effect of a mutation on the stability of dPGM per monomer following 
eq 3.2 as described in the Results. Note that ΔΔGU−N° in eq 3.1 is equivalent to 
ΔΔGI−N°/2 + ΔΔGU−I° in eq 3.2. When global fitting was performed, an average φeq-value 
was calculated from the individual φeq-values for equilibrium unfolding at each NaCl 







structure (PDB code: 1E59) of dPGM manually with the software PyMol (Schrödinger 
LLC, New York, NY). 
 
3.5.5 Hydrogen/deuterium exchange coupled with mass spectrometry 
For HDX-MS, dPGM samples were prepared at a concentration of 100 μg/mL in 20 mM 
TrisHCl−NaOH (pH 8.0) at three urea concentrations: 0 M, 2.5 M, and 5.0 M. One 
dPGM sample was also prepared containing 1.0 mM ATP to stabilize the native state. 
The dPGM samples were equilibrated overnight at room temperature. Again, the urea 
concentrations were determined from the refractive index of a stock solution (Pace, 1986). 
Deuterated buffers were prepared by lyophilizing TrisHCl−NaOH (pH 8.0) at three urea 
concentrations (0 M, 2.5 M, and 5.0 M) and reconstituting it with D2O. Four rounds of 
lyophilization were carried out, each time reconstituting the buffer with D2O. Solutions 
for the control were prepared by reconstituting buffer containing no urea using H2O.  
 
To initiate deuterium exchange, 4.0 μL of a dPGM sample was mixed with 36.0 μL of the 
respective deuterated buffer or the control buffer. HDX pulse labeling was carried out in 
triplicate for two minutes. The reaction was then quenched using 80.0 μL quench buffer 
(0.2% FA + 5% methanol, 4.5 M urea at pH 2.5) followed by flash freezing with liquid 
nitrogen. Samples were analyzed by LC/MS (Agilent 1200 LC, 6520 ESI-QTOF, Agilent 
Technologies, Santa Clara, CA). Each sample was eluted with a mobile phase of 0.1 % 
formic acid in LC/MS-grade water for isocratic elution; gradient elution was achieved 







LC/MS-grade acetonitrile (solvent B). An isocratic flow was maintained for 1.5 minutes 
followed by a gradient from 25% solvent B to 70% solvent B over 6 minutes.  dPGM was 
digested online by a column containing immobilized pepsin beads (Thermo Fisher 
Scientific, Waltham, MA). The Zorbax C18 column used for peptide level analysis was 
procured from Agilent Technologies.  
 
A theoretical mass list using MassHunter (Agilent Technologies) was prepared with the 
undeuterated control sample and was used for further analysis. Deuterium uptake for all 
peptides was calculated by HDExaminer software (Sierra Analytics, Modesto, CA). 
Briefly, the change in centroid of the peptide mass envelope relative to the control, as 
calculated by the software, was monitored for all samples. The % deuterium uptake was 
calculated from the ratio of the change in centroid mass to the number of exchangeable 
amides per peptide. Only the peptides that appeared in all the samples with good intensity 
were selected for further analysis. The % deuterium uptake for the triplicate samples of 
dPGM under each condition were averaged to obtain the mean % deuterium uptake.  
 
We defined the relative deuterium uptake as f%D in eq 3.2 to assess differences between 
the native state and the intermediate state of dPGM. The difference in f%D between native 
dPGM and the intermediate state is defined as Δf%D = f%D(native) - f%D(intermediate) and 







 intermediate relative to the globally unfolded form. Δf%D was mapped to the 
crystallographic structure (PDB code: 1E59) of dPGM manually using PyMol 









Table 3.1 Structural description the mutations implemented in E. coli dPGM 
a Determined to be residues within 4 Å of only the atoms that are removed by mutation.    
b Forms a hydrogen bond with A181. 
c Forms a hydrogen bond with a Cl- ion in the dimer interface. 
d Contact located in the opposing monomeric unit of the dPGM dimer. 
 
Variant Position Van der Waals contactsa Structural elements involved 
V8A Strand A L7, R9, I180, A181 Strand A, strand D 
T22S loop Y25, V27, R61 loop, helix 3 
V27A loop S13, Q14, W15, T22, D28, R61 Helix 1, loop, helix 3 
V34A Helix 2 L29, S30, K38, N68 Helix 2, helix 3 
L43A Helix 2 L44, E47, L229, G230 Helix 2, strand F 
T56Sb Strand B I63, L66, K82 helix 3, strand C 
I63V Helix 3 V58, A75d, W76d loop, helix 3d 
L66V Helix 3 A54, L70, V80 Strand B, helix 3, strand C 
W67Ac Helix 3 I63, H64, D70d, A76d Helix 3, helix 3d 
V80A Strand C L66, L78, K82, K82d Helix 3, strand C, strand Cd 
L86V 310 helix 1 Y55, T56, Y163 Strand B, helix 6 
L94V 310 helix 2 Y91, W114 310 helix 2, helix 5 
V111A Helix 5 T102, A103, R115 Helix 4, helix 5 
L125A loop 
H90, G92, A93, D129, R131, 
Y132, L148 
310 helix 2, loop 
L147A loop 
Y132, P133, G134, Y139, 
L142, S143 
310 helix 3, 310 helix 4, loop 
V160A Helix 6 K85, T156, R159, S186 310 helix 1, helix 6, helix 8 
L169A Helix 7 W164, P170, K173 Helix 6, helix 7 
V191A Helix 8 
L187, K192, D195, L205, I207, 
Y215 
Helix 8, helix 9, strand E 
V214A Strand D L5, Y49, Y227, L229 Strand A, strand E, strand F 
I235A Helix 10 
P208, V211, Y228, L229, 
G230, N231 







Table 3.2 Thermodynamic parameters and φ-values of dPGM variants in the presence of 0.10 M NaCl 
a Fitting performed with the signal of the intermediate, YI, fixed at 355 nm. 
b ΔΔGI−N°= ΔGI−N°(variant) - ΔGI−N°(wild-type) 
c mU−I = (6.5 – mI−N)/2  
d ΔΔGU−I°= ΔGU−I°(variant) – ΔGU−I°(wild-type) 



















V8Aa 4.32 ± 0.06 15.3 ± 0.1 1.3 ± 0.1 1.09 ± 0.03 2.62 ± 0.09 -3.9 ± 0.2 1.2 ± 0.1 
V34A 3.18 ± 0.08 14.0 ± 0.1 0.0 ± 0.1 1.66 ± 0.04 5.4 ± 0.2 -1.1 ± 0.3 1.0 ± 0.4 
L43A 3.04 ± 0.07 14.2 ± 0.1 0.2 ± 0.1 1.73 ± 0.04 5.5 ± 0.1 -1.0 ± 0.2 1.1 ± 0.4 
T56S 3.40 ± 0.06 14.4 ± 0.1 0.4 ± 0.1 1.55 ± 0.03 4.9 ± 0.1 -1.6 ± 0.2 1.1 ± 0.2 
I63V 3.36 ± 0.02 13.79 ± 0.05 -0.23 ± 0.06 1.57 ± 0.01 4.80 ± 0.05 -1.7 ± 0.2 0.9 ± 0.2 
L66V 3.45 ± 0.04 14.01 ± 0.08 -0.01 ± 0.09 1.53 ± 0.02 4.43 ± 0.05 -2.1 ± 0.2 1.0 ± 0.1 
V80A 3.45 ± 0.01 13.60 ± 0.02 -0.42 ± 0.04 1.53 ± 0.01 4.78 ± 0.04 -1.7 ± 0.2 0.9 ± 0.1 
L86V 3.64 ± 0.01 12.59 ± 0.06 -1.43 ± 0.07 1.43 ± 0.01 4.58 ± 0.01 -1.9 ± 0.2 0.73 ± 0.09 
V111Aa 3.8  ± 0.1 15.3 ± 0.3 1.3 ± 0.3 1.36 ± 0.06 3.6 ± 0.1 -2.9 ± 0.2 1.3 ± 0.2 
V160A 3.7 ± 0.1 13.7 ± 0.2 -0.3 ± 0.2 1.41 ± 0.05 3.9 ± 0.2 -2.6 ± 0.3 0.9 ± 0.1 
V191A 3.07 ± 0.03 14.4 ± 0.8 0.4 ± 0.8 1.72 ± 0.02 4.69 ± 0.09 -1.8 ± 0.2 1.1 ± 0.3 
































0.020 2.60±0.04 11.30±0.05 -1.19±0.06 1.95±0.02 6.72±0.08 0.1±0.2 -0.3±0.5 
-0.19±0.08 0.050 − 12.05±0.06 -1.30±0.07 − 6.62±0.08 0.1±0.2 -0.2±0.4 
0.10 − 12.71±0.07 -1.3±0.1 − 6.56±0.08 0.1±0.2 -0.1±0.4 
V27A 
0.020 2.74±0.04 11.55±0.05 -0.9±0.1 1.88±0.02 6.66±0.08 0.1±0.2 -0.1±0.5 
0.0±0.1 0.050 − 12.15±0.06 -1.2±0.1 − 6.46±0.08 0.0±0.2 0.1±0.3 
0.10 − 12.91±0.07 -1.1±0.1 − 6.45±0.07 0.0±0.2 0.1±0.4 
W67A 
0.10 2.89±0.02 10.12±0.02 -3.90±0.04 1.81±0.01 5.93±0.04 -0.6±0.2 0.23±0.08  
0.20 − 10.50±0.02 -4.13±0.05 − 5.85±0.02 -0.8±0.2 0.27±0.07 0.25±0.02 
0.50 − 11.01±0.02 -4.29±0.05 − 6.23±0.04 -0.8±0.2 0.26±0.07  
L94V 
0.020 2.56±0.04 10.59±0.05 -1.90±0.06 1.97±0.02 6.81±0.07 0.2±0.2 -0.3±0.3  
0.050 − 11.22±0.05 -2.13±0.06 − 6.60±0.07 0.1±0.2 -0.1±0.2 -0.1±0.1 
0.10 − 11.71±0.06 -2.31±0.06 − 6.50±0.07 0.0±0.2 0.0±0.2  
L125Af 
0.10 1.97±0.04 9.25±0.04 -4.77±0.06 2.05±0.08 6.9±0.3 0.4±0.4 -0.2±0.2  
0.20 − 9.70±0.05 -4.93±0.07 − 6.9±0.3 0.3±0.4 -0.1±0.2 -0.20±0.05 








a ΔΔGI−N°= ΔGI−N°(variant) - ΔGI−N°(wild-type) 
b mU−I = (6.5 – mI−N)/2  
c ΔΔGU−I°= ΔGU−I°(variant) – ΔGU−I°(wild-type) 
d φeq-values are calculated following eq 3.2.
 
eAverage φeq is calculed from the three φeq-values for each dPGM variant.  




0.10 2.77±0.01 10.10±0.01 -3.92±0.04 1.87±0.01 5.86±0.01 -0.6±0.2 0.20±0.08  
0.20 − 11.10±0.02 -3.53±0.05 − 6.19±0.03 -0.4±0.2 0.20±0.09 0.21±0.03 
0.50 − 11.83±0.02 -3.47±0.05 − 6.56±0.03 -0.4±0.2 0.20±0.09  
L169A 
0.020 2.91±0.04 13.22±0.07 0.73±0.08 1.80±0.02 5.37±0.09 -1.2±0.2 1.4±0.4  
0.050 − 14.10±0.08 0.75±0.09 − 5.24±0.08 -1.3±0.2 1.4±0.4 1.43±0.02 










Figure 3.1 Structure of dPGM showing the location of point mutations 
The sequence of dPGM (A) is displayed with the location of point mutation denoted by a 
dot beneath the corresponding residue. A dash follows the last residue resolved in the 
crystal structure of dPGM (Ala240). The secondary structural units are labeled above the 
corresponding residues and residues are colored to match the secondary structural 
features as displayed in the crystal structure of the dPGM dimer (B,C) (PDB entry 1E59). 
The secondary structural features of dPGM are rainbow colored (blue to red) from the N- 
to C-terminus and loops are colored gray. The orientation of dPGM in (C) is rotated 180° 
relative to (B). The side chains of the residues chosen for mutation are shown. A Cl- ion 



















Figure 3.2 Effect of mutation on the CD spectra dPGM 
The CD spectra of (A) V8A (─), T56S (─), L66V (─), and V80A (─) dPGM were 
examined in 20 mM TrisHCl−NaOH  (pH 8.0). The spectra of wild-type dPGM (─ ─) is 
shown for reference. The CD spectra of the other variants were examined in the presence 
of 0.10 M NaCl as follows: (B) T22S (─), V27A (─),  V34A (─), L43A (─), I63V (─), 
and W67A (─) dPGM; (C) L86V (─), L94V (─), V111A (─), L125A (─), and L147A (─) 
dPGM; (D) V160A (─), L169A (─), V191A (─), V214A (─), and I235A (─) dPGM. The 
















Figure 3.3 Effect of mutation on the elution of dPGM from size exclusion 
chromatography  
The absorbance at 280 nm was monitored during size exclusion chromatography of (A) 
wild-type dPGM (─), L86V (─), V111A (─), and V214A (─) dPGM without added salt. 
(B) Size exclusion was also monitored in the presence of 0.15 M NaCl for wild-type 
dPGM (─) and the following variants: (B) V8A (─), T22S (─), V27A, (─) V34A (─), 
and L43A (─) dPGM; (C) T56S (─), I63V (─), L66V (─), W67A (─), V80A (─), and 
L94V (─) dPGM; (D) L125A (─), L147A (─), V160A, (─) L169A (─), V191A (─), and 




















Figure 3.4 Effect of point mutations on the equilibrium unfolding of dPGM  
The equilibrium unfolding of the following dPGM variants was monitored by 
fluorescence in the presence of 0.10 M NaCl: (A) V8A (●), V34A (■), L43A (□), and 
T56S (○) dPGM; (B) I63V (●), L66V (□), V80A (■), and L86V (○) dPGM; (C) V111A 
(○), V160A (●), V191A (■), and I235A (□) dPGM. The data were fit with eq 2.4 (solid 
line), and the fitting results are listed in Table 3.2. The fitting result for wild-type dPGM 

































Figure 3.5 Effects mutation upon dPGM in the presence of NaCl 
The equilibrium unfolding of (A) T22S, (B) V27A, (C) W67A, (D) L94V, (E) L125A, (F) 
L147A, and (G) L169A dPGM was monitored by tryptophan fluorescence under three 
different NaCl concentrations. The concentration of NaCl is denoted as follows: 0.02 M 
(■), 0.05 M (), 0.10 M (▲), 0.20 M ( ) and 0.50 M (●). The equilibrium unfolding of 
each variant was fit globally by eq 2.4 (solid lines), and the resulting thermodynamic 
parameters are listed in Table 3.3. The fitting result for wild-type dPGM unfolding in the 




























Figure 3.6 Deuterium uptake of the dPGM dimer, intermediate, and unfolded form 
(A) The mean % deuterium uptake for peptides from dPGM in the native state (gray), 
intermediate state (blue), and unfolded state (red). (B) The fraction of relative deuterium 
uptake, f%D, for each peptide from the native state (gray) and the intermediate state (blue), 
where 1.0 signifies the same amount of deuterium uptake as the unfolded state. The f%D 




















Figure 3.7 A structural view of the differences between native dPGM and the intermediate 
state. 
(A, B) The φeq-values (Tables 3.2, 3.3) are mapped to the crystal structure of dPGM 
(PDB entry 1E59) with the mutated side chains displayed and colored blue to red for φeq-
values of 1 to 0, respectfully. (C, D) The difference in relative deuterium uptake between 
the native state and the intermediates state, Δf%D, is mapped to the crystal structure of 
dPGM with the values of Δf%D ranging from 0 to -0.81 colored as blue to red, respectfully. 
The orientation of dPGM in (B) and (D) is rotated 180° about the vertical axis relative to 





























Figure 3.8 The structure of the dPGM intermediate. 
The structure of the dPGM intermediate is mapped to the crystal structure of the native 
monomer (PDB entry 1E59) with the unfolded loop region denoted as red and its 
backbone depicted as a ribbon. α-helices 1, 4, and 5 (red) are depicted as tubes and 
appear to lose contact with other structural units in the intermediate state but retain some 
local structure. The orange interface region and gray stable core regions, displayed as a 
cartoon, both remain folded in the intermediate. The interface region loses many contacts 
from the unfolding of the loop region and dissociation of the dimer. The structure in (B) 
is rotated 180° about the vertical axis relative to (A). The α-helices (α), 310-helicies (θ), 




























CHAPTER 4. EFFECT OF A PHYSIOLOGICAL MILEAU ON THE ENERGETICS 
OF METABOLITE BINDING BY ESCHERICHIA COLI PHOSPHOGLYCERATE 
MUTASE  
4.1 Summary 
The chemical environment of the cell offers protein a multitude of potential binding 
partners. Escherichia coli cofactor-dependant phosphoglycerate mutase (dPGM) has been 
demonstrated to bind non-substrate metabolites such as ATP and other nucleotides in 
vitro. dPGM is a homodimeric protein and was found to populate a partially unfolded, 
monomeric intermediate during equilibrium unfolding. Partially unfolded protein are 
often more accessible than the globally unfolded form and can misfold, aggregate, or 
trigger disease states. Binding to ligand selectively promotes the dPGM dimer and 
reduces monomer populations. Here, we seek to understand the physiological relevance 
of the interactions between dPGM and the chemical environment. We investigated how 
physiological salt conditions impact the stabilizing effect of metabolites and ATP binding. 
Salt reduces the interactions between dPGM and metabolites, but also selectively 
enhances the stability of the dimer. Through mutagenesis we identify three residues that 
appear to bind chloride: Trp67, Lys99, and R115A. Many anions and anionic metabolites 
interact with dPGM at physiologically relevant concentrations. We find that the presence 
of 0.10 M NaCl, 5.0 mM MgCl2, and 1.0 mM ATP more than doubles the effective free 








 between ligand binding and dimerization in dPGM allows the enzyme to utilize a 
multitude of abundant anions to drastically increase the energy gap between a partially 
unfolded intermediate and the native state in a physiological milieu.  
         
4.1 Introduction 
Often protein folding is regarded as a cooperative, two-state transition and is investigated 
using small, monomeric protein. However, the majority of the proteome is comprised of 
oligomers and in Escherichia coli dimeric proteins are, by far, the most populous form 
(Braselmann et al., 2013). Often, dimeric proteins are found to populate partially 
unfolded intermediates in vitro (Rumfeldt, Galvagnion, Vassall, & Meiering, 2008). In 
the cellular environment, significant partial unfolding can lead to proteolytic digestion 
(Hubbard, 1998), misfolding (Dobson, 2003), and aggregation (Horwich, 2002). Both 
misfolding and aggregation may causes disease states (Thomas et al., 1995). With partial 
unfolding being so risky, many dimeric proteins likely avoid partial unfolding in their 
physiological milieu. Substrate binding offers a facile way to promote binding-competent 
protein conformations, but substrate may not always be maintained at saturating levels 
and not all protein have a substrate. A theoretical analysis of the evolutionary effects of 
random mutation on a protein in the presence of various small molecules has predicted 
that proteins may frequently evolve nonfunctional binding sites that aid in stability 
(Manhart & Morozov, 2015). By stabilizing the native protein, nonfunctional interactions 
actually bolster enzyme activity and can, therefore, be indirectly selected for by natural 
selection (Manhart & Morozov, 2015). Large-scale screens for weak protein-metabolite 








with no known function (Li, Gianoulis, Yip, Gerstein, & Snyder, 2010; Orsak et al., 
2011). These screens suggests that nonfunctional binding interactions are common and 
may play an integral role in stabilizing folded protein over partially unfolded 
intermediates.  
 
The cofactor-dependent phosphoglycerate mutase (dPGM) enzymes take part in 
glycolysis and gluconeogenesis. The dPGM enzymes are dependent on the cofactor 2,3-
bisphosphoglycerate for activation. As a phosphatase (EC 3.1.3.13), dPGM converts 2,3-
bisphosphoglycerate into 2-phosphoglycerate or 3-phosphoglycerate while retaining a 
phosphate group on a conserved, active-site histidine. Once phosphorylated, dPGMs 
catalyze the reversible isomerization reaction between 2-phosphoglycerate and 3-
phosphoglycerate, fulfilling their primary role as a mutase (EC 5.4.2.11). In proteome 
wide screens, both E. coli dPGM and Saccharomyces cerevisiae dPGM have been 
identified as ATP-binding protein (Chang et al., 2012; Tran et al., 2014). However, the 
enzymatic activity of dPGM does not require ATP, and assays that monitor the mutase 
activity have been observed in the presence and absence of ATP with no notice of an 
effect from the presence of ATP (Fraser et al., 1999). 
 
Previously, we determined that ATP can bind in the active site of the homodimeric E. 
coli dPGM; the active site of dPGM is energetically coupled with the dimer interface 
such that ligand binding and dimerization promote one another (Chapter 2). dPGM was 
found to readily populate a partially unfolded, monomeric intermediate but ligand 








reduces the population of the intermediate. The stabilizing effect of ATP on dPGM 
appears to be shared by other nucleotides and phosphates (Chapter 2). Further, the crystal 
structures of active and inactive E. coli dPGM have been solved with the active site 
occupied by sulfate and tetravanadate, respectfully (Bond et al., 2001, 2002). We utilized 
ATP to elucidate the energetic coupling in dPGM under low ionic strengths (Chapter 2, 
Chapter 3). However, the activity of dPGM has been observed to be highly sensitive to 
salts and ionic strength with its maximal activity occurring below 0.1 M ionic strength 
(Grisolia & Cleland, 1968; Rose & Dube, 1978; Rose & Kaklij, 1984). Because 
metabolites appear to interact with dPGM through Coulombic interactions in the active 
site, ligand binding may also be highly dependent upon salt concentrations. E. coli dPGM 
presents a valuable three-state system to assess changes in protein energetics because it 
can highly populate a stable intermediate with a distinctive spectroscopic signal and the 
two unfolding transitions can be well separated. This allows for accurate determination of 
global stability and the energy gap between the native state and partially unfolded 
intermediate, which bears more physiological relevance (Sancho et al., 2002). 
 
Here, we seek to understand the physiological relevance of interactions between ligand 
and dPGM and the relevance of the energetic coupling between ligand binding and 
dimerization. We utilize equilibrium unfolding and isothermal titration calorimetry to 
assess the influence of metabolites, salts, and ionic strength on the stability of dPGM. In 
general, salt appears to reduce interactions between metabolites and dPGM while still 
acting to reduce the accessibility of the intermediate. Through site-directed mutagenesis 








Our results highlight the sensitivity of dPGM to its environment and its ability to harness 
the chemical environment to dramatic increase stability of the native dimer over the 
intermediate. The energetic coupling between ligand binding and dimerization in dPGM 
appears pivotal for governing the enzyme’s stability under a physiological milieu.  
 
4.1 Results  
4.1.1 Effect of PEP and citrate on the thermodynamic stability of dPGM 
Previously, dPGM was shown to be stabilized by nucleotides through interactions with 
the phosphate groups (Chapter 2). The cellular environment contains many more anionic 
metabolites and here we examined the equilibrium unfolding of dPGM in the presence of 
1.0 mM phosphoenolpyruvate (PEP) and 1.0 mM citrate (Figure 4.1) to understand 
whether the stabilizing effect observed with the nucleotides is shared by other anionic 
metabolites. The equilibrium unfolding of dPGM was monitored by intrinsic tryptophan 
fluorescence. As shown in Figure 4.1, equilibrium unfolding of dPGM appears 
cooperative with a transition midpoint, Cm, of approximately 3.3 M urea in the presence 
of both citrate and PEP. Global fitting of the equilibrium unfolding data in the absence 
and presence of citrate and PEP allowed us to apply the three-state model to all data sets 
to obtain thermodynamic parameters (Table 4.1). 1.0 mM Citrate increases ΔGI−N° by 6.1 
± 0.3 kcal/mol and 1.0 mM PEP increases ΔGI−N° by 6.7 ± 0.3 kcal/mol. PEP confers 
greater stability to dPGM than the more negatively charged citrate or ADP, but PEP is 
less stabilizing than ATP (Table 2.2). PEP is close in structure to the dPGM substrate 2-
phosphoglycerate, which apparently causes PEP to display a larger stabilizing effect than 








citrate does not contain phosphate, yet it still dramatically stabilizes dPGM just like the 
phosphorylated metabolites.  
 
4.1.2 Effect of salt on the stabilizing effect of anionic metabolites 
In the cellular environment Mg2+ chelation and ionic strength likely affect the Coulombic 
interactions between anionic metabolites and dPGM. To examine these two factors, we 
performed equilibrium unfolding of dPGM in the presence of 1.0 mM ATP, and in the 
presence of 1.0 mM citrate under the following salt conditions: 5.0 mM MgCl2 (Figure 
4.2A), 0.10 M NaCl (Figure 4.2B), 5.0 mM MgCl2 and 0.10 M NaCl (Figure 4.2C). 
Under each salt condition, the midpoint of the first unfolding transition, Cm1, is shifted to 
higher urea concentrations while the midpoint of the second unfolding transition is 
slightly reduced. In the presence of 0.10 M NaCl, Cm1 is increased by about 1.0 M urea. 
In the presence of 5.0 mM MgCl2, Cm1 is increased by about 0.2 M urea. Under each salt 
condition, ATP and citrate increase Cm1 less than observed without salt. With both salts 
present, ATP and citrate only increase Cm1 by about 0.3 M urea. Notably, 5.0 mM MgCl2 
reduces the interaction between dPGM and the metabolites more than 0.10 M NaCl and 
effectively enough for equilibrium unfolding to remain clearly three-state in the presence 
of either ATP or citrate.  
 
To obtain thermodynamic parameters, the equilibrium unfolding of dPGM without a 
metabolite, with 1.0 mM ATP, and with 1.0 mM citrate were fit globally to the three-state 
model using eq. 2.4 under each salt condition (Table 4.2). Under all three salt conditions, 








was observed in the presence of 5.0 mM MgCl2 (ΔΔGI−N° = 1.5 kcal/mol) and the largest 
increase in ΔGI−N° was found in the presence of both salts (ΔΔGI−N° = 3.0 kcal/mol). 
With no added salt, 1.0 mM ATP increases ΔGI−N° by 7.0 kcal/mol (Chapter 2) and 1.0 
mM citrate increases ΔGI−N° by 6.7 kcal/mol. With 5.0 mM MgCl2 present, the stabilizing 
effect of both metabolites is sharply reduced with 1.0 mM ATP and 1.0 mM citrate 
raising ΔGI−N° by only 2.6 ± 0.1 and 2.7 ± 0.1 kcal/mol, respectively. The presence of 
0.10 M NaCl has a less dramatic effect on the stabilizing effect of ATP than on that of 
citrate; the stabilizing effect of citrate is halved while the effect of ATP is hardly 
attenuated. In the presence of both salts, 1.0 mM ATP and 1.0 mM citrate minimally 
enhance ΔGI−N°; under this condition, the two salts stabilize dPGM three-fold more than 
the metabolites. The stability of the intermediate state (ΔGU−I°) does not show a 
dependence on the presence of salt or metabolite.  
 
The m-value is proportional to the change in solvent accessible surface area upon 
unfolding or the surface area buried upon folding (Myers et al., 1995). For dPGM without 
added salt, mI−N is 2.40 kcal∙mol
-1M-1, mU−I is 1.86 kcal∙mol
-1M-1, and mU−N is 3.06 
kcal∙mol-1M-1 per monomer (Chapter 2). The presence of 0.1 M NaCl shows no effect on 
mI−N, but when MgCl2 is present, mI-N is greater than without salt. In the presence of 5.0 
mM MgCl2, both unfolding transitions are clearly visible (Figure 4.2A) in all data sets, 
and this results in the most robust fit and m-value determination; here, mI−N is 3.09 ± 0.05 
kcal∙mol-1M-1 (1.55 kcal∙mol-1M-1 per monomer) and mU−I is 1.65 ± 0.03 kcal∙mol
-1M-1, 
which results in a mU−N of 3.2 ± 0.04 kcal∙mol
-1M-1 per monomer. In the presence of 5.0 








based off the number of amino acids in the protein (Myers et al., 1995). The value of mU−I 
decreases when only MgCl2 is present and increases when NaCl is also present (Table 
4.2). The differences in mU−I most likely result from the poor resolution of the 
intermediate state signal and the second unfolding transition in the equilibrium unfolding 
of dPGM under both conditions including NaCl. Our results suggest the presence of Mg2+ 
allows the native state of dPGM to adopt a slightly more compact form than without salt 
and the presence of NaCl does not affect the solvent exposed surface area of dPGM. 
 
4.1.3 The effect of salt on ATP binding  
To directly assess the effect of MgCl2 and NaCl on metabolite binding, we determined 
the dissociation constant (Kd) for ATP binding by dPGM under all three salt conditions 
using isothermal titration calorimetry (ITC) (Figure 4.3). We previously determined the 
Kd for dPGM-ATP binding without added salt (0.32 μM). When 5.0 mM MgCl2 was 
included in the assay, Kd was increased to 37 ± 8 μM. When 0.10 M NaCl was included, 
Kd was determined to be 2.9 ± 0.2 μM. In the presence of both 5.0 mM MgCl2 and 0.10 
M NaCl, no binding was observed. During the ITC experiments 0.40 mM ATP was 
injected into the sample and only a Kd at least seven-fold lower (~60 μM) should be 
detected by ITC (Duff, Grubbs, & Howell, 2011). From the stabilizing effect of ATP in 
the presence of MgCl2 and NaCl (ΔΔGI−N° = 0.9 kcal/mol), determined from equilibrium 
unfolding, the Kd for ATP binding in the presence of both salts was estimated to be 0.76 
mM following eq. 2.6. The Kd for ATP binding in the presence of 5.0 mM MgCl2 or 0.10 
M NaCl calculated from the results of equilibrium unfolding are 0.13 mM and 0.010 mM, 








greater than those determined by ITC, which could be due to the high urea concentrations 
used to unfold dPGM. A 3.5-fold reduction in the Kd for ATP binding in the presence of 
both salts, as determined by equilibrium unfolding, is 0.22 mM. Overall, the ITC results 
corroborate the effects of MgCl2 and NaCl observed in the equilibrium unfolding of 
dPGM.  
 
Naturally occurring ATP usually exists as in a metal-chelated form; Mg2+ binds to ATP 
with a Kd of about 0.10 mM, and Na
+ binds to ATP with a Kd of about 77 mM (Wilson & 
Chin, 1991). The strong suppression of ATP binding by 5.0 mM MgCl2 suggests that 
Mg2+ and dPGM compete for free ATP. If dPGM and Mg2+ compete for ATP, the 
apparent Kd should follow the competitive binding relationship shown in eq 4.1 and 




















KK   (4.1) 
 
where Kd
app is the apparent dissociation constant for dPGM∙ATP in the presence of Mg2+, 
Kd is the dissociation constant for dPGM∙ATP in without added salt, [B] is the Mg
2+ 
concentration, and KdB is the dissociation constant for Mg∙ATP. Under our condition, 5.0 
mM MgCl2, the expected Kd
app
 is 16 μM, which is in close agreement with the value 
determined by ITC (37 μM). Competition between dPGM and Na+ for ATP is only 
expected to give a Kd
app of 0.42 μM. Rather than compete with dPGM for ATP binding, 








to competitive binding between chloride and ATP at the dPGM active site. Citrate is also 
likely to bind to magnesium as the Kd for MgCit
- is 0.28 mM at pH 7.5 (Walser, 1961). 
Following eq 2.6, the Kd for dPGM∙Citrate without added salt and in the presence of 5.0 
mM MgCl2 is 5.8 μM and 0.11 mM, respectfully. If Mg
2+ and dPGM compete for citrate 
binding, then following eq 4.1 with a Kd for dPGM∙Citrate of 5.8 μM, the Kd
app for 
dPGM∙Citrate in the presence of 5.0 mM MgCl2 is expected to be 0.11 mM, in agreement 
with Kd determined from equilibrium unfolding in the presence of 5.0 mM MgCl2. Under 
our experimental conditions, Mg2+ appears to compete with dPGM for ATP and citrate 
binding.  
 
4.1.4 Ion-specific effects on the thermodynamic stability of dPGM  
We have observed that a range on anionic molecules selectively stabilize native dPGM 
with varying strengths. To clarify ion-specific effects, we monitored the equilibrium 
unfolding of dPGM with the following physiological salts at an ionic strength of 0.10 M: 
KCl, MgCl2, NaBr, NaCl, NaF, Na2SO4 (Figure 4.4). All of the salts caused an increase 
in Cm1 with MgCl2 having the least effect and Na2SO4 causing the most dramatic 
increase. In contrast to the other salts, the presence of NaF caused a clear increase in Cm2. 
F- appears to form stabilizing interactions with the intermediate state. The monovalent 
salts all shift the apparent Cm1 to about 2.0 – 2.3 M urea. MgCl2 and Na2SO4 are clear 










Curve fitting with the three-state model (eq 2.4) reveals that all the salts increased 
ΔGI−N°, but the magnitude of the stability increase is determined by the anion (Table 4.3). 
The increase in stability of native dPGM in the presence of MgCl2 (ΔΔGI−N° = 1.97 
kcal/mol) is actually similar to the stability of dPGM in the presence of NaCl (ΔΔGI−N° = 
1.79 kcal/mol, Table 4.2) and KCl (ΔΔGI−N° = 2.19 kcal/mol) despite a significant 
difference in the apparent Cm1. With chloride as the anion, the choice of cation does not 
appear to influence the stabilizing effect of the salt on dPGM. However, the presence of 
0.10 M NaBr, NaCl, or NaF results in significantly different values of ΔΔGI−N (Table 
4.3). The most stabilizing salt, Na2SO4, bears the most charged anion and increased 
ΔGI−N° by 4.5 ± 0.1 kcal/mol. The stabilizing effects of the salts suggest that the cation 
does not influence dPGM and the observed stabilizing effects of salts are due to 
interactions with the anions. Also, the stabilizing effects of anions on ΔGI−N° appear to be 
highly specific to the ion type and, therefore, not due to ionic strength effects. 
 
We again find that MgCl2 significantly increases mI−N and KCl, NaBr, and NaF also 
increase mI−N compared to dPGM without added salt. The high m-value observed in the 
presence of MgCl2 causes dPGM to unfold at lower urea concentrations that anticipated 
given the stabilizing effect of MgCl2. The presence of NaBr or NaF raised mI−N by more 
than 0.35 kcal mol-1 M-1 compared to dPGM without added salt, which is a 10% increase. 
The effect of the salts on mI−N supports the idea that native dPGM is more expanded in 
the low ionic strength buffer without added salt. In the presence of NaF, both mU−I and 
ΔGU−I° are much greater than in buffer alone; this actually causes the global stability of 








intermediate is populated at lower urea concentrations in the presence of NaF. The 
primary effect of salt on the m-values of dPGM appears to be a small increase in mI−N 
which could signify that that native dimer is more compact in the presence of added salt 
than in buffer alone. 
 
4.1.5 Effect of NaCl concentration on the thermodynamic stability of dPGM  
In the cellular context, dPGM is likely to experience a range of salt concentrations. To 
clarify the dependence of dPGM stability on salt concentration, we examined the 
equilibrium unfolding of dPGM in presence of NaCl ranging from 0.020 M to 0.50 M 
NaCl (Figure 4.5). As the concentration of NaCl is increased, the first unfolding 
transition of dPGM shifts to higher urea concentrations, while the second transition 
remains stable. At 0.50 M NaCl, the midpoints of both transitions are close in value, and 
equilibrium unfolding of dPGM appears cooperative. The equilibrium unfolding of 
dPGM at each NaCl concentration, including in buffer alone, was fit globally with Eq. 
2.4 to obtain thermodynamic parameters (Table 4.4). As anticipated, ΔGI−N° shows a 
direct dependence upon the NaCl concentration while ΔGU−I° does not. The effect of the 
highest NaCl concentrations, 0.50 M NaCl, is a ΔΔGI−N° of 3.59 kcal/mol, which is still 
about 1 kcal/mol less than the effect of 0.33 mM Na2SO4. The effect of 0.10 M NaCl on 
ΔGI−N° as reported by the global fit (ΔΔGI−N° = 2.31 kcal/mol) is close in value to the 
effect of 0.10 KCl. The m-values for the NaCl series are mI−N = 2.61 ± 0.02 kcal∙mol
-1M-1, 
mU−I = 1.94 ± 0.04 kcal∙mol
-1M-1, and mU−N = 3.25 kcal∙mol
-1M-1 per monomer. The m-
values determined by the global fitting are more robust and are slightly greater in value 








the presence of NaCl is in agreement with value determined in the presence of 5.0 mM 
MgCl2 and the theoretical value based on the dPGM sequence. The primary effect 
increasing NaCl concentrations is an enhancement of ΔGI−N°.  
 
4.1.6 The effect of point mutations on the chloride-induced stabilization of dPGM. 
Two regions of dPGM are prime candidates for interactions between dPGM and chloride 
ions: the active site and the dimer interface. The crystallographic structure of dPGM 
reveals an extremely basic active site and a chloride ion bound in the dimer interface 
between Trp67 and Lys82 from each monomer (Figure 4.6) (Bond et al., 2001, 2002). 
We have found that ATP binds in the dPGM active site (Chapter 2) and here, we have 
shown that salts can stabilize dPGM similar to ATP. To probe the involvement of the 
dimer interface and the active site of dPGM in binding to chloride, we analyzed the effect 
of NaCl on three dPGM Variants: W67A, K99A, and R115A dPGM (Figure 4.7A, B, C). 
W67A dPGM was previously characterized in the presence of 0.10 M to 0.50 M NaCl 
(Chapter 3) and found to be greatly destabilized, but still able to fold to the native state. 
Lys99 and Arg115 are located in the active site and were previously shown to be 
involved in ATP binding (Chapter 2). The effect of NaCl on the stability of the three 
dPGM variants is compared with wild-type and K222A dPGM (Figure 4.7D). The 
K222A mutation will test the effect of removing a charged side chain distal to the active 
site and dimer interface (Figure 4.6). If a side chain is involved in forming stabilizing 
interactions with chloride, then an alanine mutation should result in a less favorable 
interaction between chloride and dPGM. A decrease in the favorability of the interaction 








dPGM. To compare the stabilizing effect of chloride upon each variant, we conducted 
equilibrium unfolding at several NaCl concentrations for each variant (Figure 4.7).  
 
For all dPGM variants, equilibrium unfolding at each NaCl concentration and without 
added salt were fit globally using eq 2.4 (Table 4.5). We find that the W67A mutation 
reduced ΔGI−N° by 3.22 kcal/mol relative to wild-type dPGM without added salt. Using 
the thermodynamic parameters, the fractional population of the W67A dPGM 
intermediate state was determined to be 0.47 at 0 M urea without added salt. In the 
presence of 0.5 M NaCl, the population of the W67A dPGM intermediate state is reduced 
to 0.07 with the rest being native dPGM. For each dPGM variant, the ΔGI−N° increases 
alongside the NaCl concentration. At each concentration of NaCl, the ΔΔGI−N° for W67A 
dPGM is significantly reduced compared to wild-type dPGM, where ΔΔGI−N° = 
ΔGI−N°(NaCl) − ΔGI−N°(no salt). In the presence of 0.20 M NaCl, the ΔΔGI−N° for wild-
type is dPGM is 0.8 kcal/mol more than the ΔΔGI−N° for W67A dPGM. Clearly some 
stabilizing interactions with chloride are lost from the W67A mutation. Both K99A and 
R115A dPGM are more stable than wild-type at each NaCl concentration. For K99A 
dPGM, ΔΔGI−N°is significantly less than that of wild-type dPGM at NaCl concentrations 
of 0.050 mM or greater. R115A dPGM shows a ΔΔGI−N° that is significantly less than 
wild-type dPGM at NaCl concentrations of 0.10 M or greater (Table 4.5). Both active-site 
mutations reduce ΔΔGI−N° in the presence of NaCl, but much less than the W67A 
mutation. For K222A dPGM, the effect of NaCl appears nearly identical to the effect on 
wild-type dPGM (Table 4.5). W67A, K99A, and R115A dPGM are less stabilized by 








R115A dPGM supports the role of the dimer interface and active site in binding chloride. 
The W67A mutation was the most efficacious mutation in reducing ΔΔGI−N° which 
suggests that chloride binding at the dimer interface is highly dependent upon Trp67. The 
dPGM active site contains many positively charged residues and  the effect of NaCl on 




We have demonstrated that the native state of dPGM is selectively stabilized over a 
partially unfolded, monomeric intermediate by many abundant, anionic metabolites and 
salts that dPGM will encounter in the cellular environment. For example, the intracellular 
citrate and PEP concentrations in glucose-fed E. coli are about 2.0 mM and 0.18 mM, 
respectfully (Bennett et al., 2009). The concentration of citrate and PEP that we used (1.0 
mM) appears relevant to the physiological milieu. Although several anionic metabolites 
show a tight binding to dPGM in buffer, the effect of physiological salts, especially Mg2+, 
will greatly reduce metabolite binding (Figure 4.2). However, we observed that citrate 
and ATP still bind to dPGM in the presence of excess MgCl2 and NaCl which suggests 
that they may bind dPGM in the E. coli cytosol. While salt reduces the ability of 
metabolites to stabilize dPGM, small anions like chloride compensate for the reduction 
and selectively enhance the stability of native dPGM. Previously, we described an 
energetic linkage between the active site of dPGM and the dimer interface (Chapter 2). 
Investigation into the structure of the equilibrium intermediate of dPGM revealed the 








cooperativity between the two sites gives rise to allostery between dimerization and 
ligand binding. Interestingly, the effects of NaCl on W67A, K99A, and R115A dPGM 
suggest that chloride binds to both of the allosteric sites.  
 
For protein with an equilibrium intermediate, the energy gap between the native protein 
and the first inactive intermediate, ΔGI−N°, is the most relevant to conformational stability 
as the intermediate is the most likely non-native confirmation to be populated (Sancho et 
al., 2002). To put the stabilizing effect of salts and metabolites on dPGM in perspective, 
we determined the effective stability, ΔGeff = -RT ln[(1 − fN)/fN], (Park & Marqusee, 
2004a) of dPGM at 0 M urea from the ratio of nonnative to native protein, (1 − fN)/fN. 
The effective stability is comparable amongst protein of varying oligomeric state, and it 
takes into account the relevant stability. Without added salt, the effective stability of 1 
μM dPGM is 1.9 kcal/mol; in the presence of 5.0 mM MgCl2, 0.10 M NaCl, and 1.0 M 
ATP, the effective stability of 1 μM dPGM is 3.9 kcal/mol. The presence of salt and a 
metabolite doubled the effective stability of dPGM. Without urea and in only 20 mM 
buffer, 1 in 25 dPGM monomers should adopt the intermediate conformation. With a 
ΔGeff of 3.9 kcal/mol, about 1 in every 750 dPGM monomers should adopt the 
intermediate conformation. E. coli dPGM appears to have evolved to interact with 
abundant anions and metabolites to achieve a proper stability in its physiological milieu.  
 
The interactions between protein and salt can involve any combination of preferential 
solvation, Hofmeister effects, electrostatic interactions arising from the ionic strength as 








Plaxco, 2005; Record Jr, Zhang, & Anderson, 1998). With dPGM we observed 
specificity for the anion type and that ionic strength did not explain the effects of salt on 
ΔΔGI−N° (Table 4.3). Therefore, we expected that chloride forms specific binding 
interactions with dPGM. The effect of NaCl on the three dPGM variants, W67A, K99A, 
and R115A dPGM confirmed that chloride forms specific interactions with dPGM to 
stabilize the native state over the intermediate. Because the crystallographic structure of 
dPGM shows that Trp67 forms interactions with a buried chloride ion (Bond et al., 2001, 
2002), removal of the Trp67 side chain should reduce the stabilizing effect of NaCl. 
Compared to wild-type dPGM the ΔΔGI−N° due to NaCl for W67A dPGM is, on average, 
26% lower. W67A dPGM is still greatly stabilized in the presence of NaCl, which 
suggests that the majority of the stabilizing effect of NaCl is due to chloride binding 
within the active site. The presence of chloride is more stabilizing for K99A and R115A 
dPGM than for W67A dPGM. The large active site of dPGM contains many positively 
charged side chains (Bond et al., 2001), and we expect that multiple chloride ions can 
bind, especially considering that the active site accommodates substrate bearing multiple 
phosphate groups. The lesser reduction in the ΔΔGI−N° of K99A and R115A dPGM 
compared to wild-type dPGM supports the idea that multiple chloride ions bind within 
the active site. The investigators who solved the structure of the homologous human 
dPGM postulated that low concentrations of chloride primarily stabilize the quaternary 
structure of dPGM while higher concentrations primarily stabilize the active site (Yanli 
Wang et al., 2005). Our results suggest that chloride binds with greater affinity at the 








of dPGM causes binding at either site to stabilize the quaternary structure and the active 
site (Chapter 3).  
 
Although we demonstrated the stabilizing effects of metabolites and salts on dPGM in 
vitro, the observed effects seem to be relevant to the stability of dPGM in the E. coli 
cytosol. First, about 1.4 × 104 copies of dPGM exists per E. coli cell (Ishihama et al., 
2008), which amounts to about 14 μM after accounting for cell volume (Kubitschek & 
Friske, 1986). This concentration is 14-fold greater than that in most of our experiments 
and will stabilize the native dimer relative to our conditions. During our investigation, we 
kept the concentrations of metabolites within physiologically relevant ranges. Here and in 
our energetics-based proteomics screen where dPGM was identified (Chang et al., 2012), 
we used 1.0 mM ATP to approximate the concentration of free ATP in the E. coli cytosol 
(Schneider & Gourse, 2004). We observed that GTP as well as ATP stabilizes dPGM 
extensively (Chapter 2), which suggests that any nucleotides in cells can contribute to the 
stability of the protein. The total intracellular pool of triphosphate nucleotides (NTPs) in 
glucose-fed E. coli is about 27 mM (Bennett et al., 2009). Though a large fraction of the 
NTPs are bound to proteins and the concentration of free NTPs would be significantly 
lower than 27 mM, the intracellular pool of NTPs, plus the diphosphate and 
monophosphate nucleotides, should convey more stability to the protein than we 
observed with 1.0 mM ATP. As mentioned, the intracellular citrate and PEP 
concentrations are also relevant. We have shown that just 0.1 mM pyrophosphate 
increases dPGM stability such that equilibrium unfolding appears cooperative (Chapter 








E. coli growth cycle (Jukka & Harold, 1988). Therefore, several of the metabolites we 
examined were present at physiologically relevant concentrations. 
 
Anions compete with the metabolites to stabilize dPGM primarily through interactions in 
the active site. We observed that both ATP and citrate binding to dPGM was drastically 
attenuated by 0.1 M NaCl and 5.0 mM MgCl2 (Table 4.2). The intracellular chloride 
concentration of E. coli has a linear dependence on the extracellular concentration and 
does not appear to be tightly regulated (Schultz, Wilson, & Epstein, 1962). Many strains 
of E. coli can grow with up to 0.5 M extracellular NaCl (Kunin, Hua, Van Arsdale White, 
& Villarejo, 1992); the entire range of NaCl concentrations used in this study could be 
experienced by E. coli. Free Mg2+ concentrations are thought to be low, on the order of 1 
to 2 mM (Alatossava, Jütte, Kuhn, & Kellenberger, 1985), which is less than the 
concentration in our experiments. Although pin pointing how much each metabolite or 
anion contributes to the stability of dPGM in E. coli cells is not feasible, our data strongly 
suggest that salts will greatly reduce, but not eliminate, interactions between dPGM and 
metabolites. Based on the effect of ATP and Citrate on the stability of dPGM in presence 
of salt (Table 4.2), salts likely confer more stability to dPGM than metabolites under a 
physiological milieu. Still, our results suggest that dPGM is able to bind the metabolites 
in the cytosol. Collectively, the metabolites and anions in the cellular environment should 










Because most interactions between metabolites or salts and dPGM appear to occur in the 
active site of dPGM, metabolites and salts may inhibit catalysis by dPGM. However, as 
long as the inhibition is competitive, a sufficient amount of the substrate would overcome 
the inhibition. Activity studies on chicken breast dPGM have demonstrated that several 
anions competitively inhibit substrate binding to dPGM (Rose & Dube, 1978; Rose & 
Kaklij, 1984). The total 3-phosphoglycerate (3-PG) concentration in glucose-fed E. coli 
has been found to be 1.5 mM (Bennett et al., 2009). The reported Km values for 3-PG and 
2-PG are 0.20 ± 0.03 mM and 0.19 ± 0.04 mM, respectfully (Fraser et al., 1999). The 
main catalytic activity of dPGM is driven by the equilibrium constant between 3-PG and 
2-PG and must function in opposite directions for glycolysis and gluconeogenesis. A low 
Km value would suggest that product is released rapidly, but a consequence would be 
rapid release of substrate in the reverse reaction (Bennett et al., 2009). Therefore, 
reversible reactions tend to have large Km values so substrate binding is productive and to 
maintain sensitivity to substrate flux (Bennett et al., 2009). The Km value for 3-PG 
determined with chicken breast dPGM was found to increase with the square of the KCl 
concentration (Rose & Dube, 1978). Km values determined for many enzymes are below 
the concentrations of their substrates in E. coli, which should cause enzyme saturation 
and insensitivity to metabolic flux; however, competitive inhibition from other 
metabolites or salts may bring up the Km value for the substrate to an adequate level for 
enzymes to be sensitized to the substrate concentration (Bennett et al., 2009). An 
ordinary-differential-equation-based modeling of the central nitrogen metabolism in E. 
coli predicts that competition for saturated enzyme active sites maintains sensitivity to 








even predicted to occur from non-functional or non-substrate metabolites (Yuan et al., 
2009). The non-substrate metabolites we examined may competitively inhibit dPGM in 
the E. coli cytosol. If high ATP concentrations inhibit the mutase activity of dPGM, ATP 
binding could serve as a negative feedback loop to slow glycolysis. The effects of anions 
on dPGM, that we observed, suggest that physiological anions and metabolites will 
greatly increase Km values for 3-PG and 2-PG compared to those determined for E. coli 
dPGM in vitro.  
 
Under the right conditions, could dPGM have activity for several of the metabolites 
(ATP, citrate, and pyrophosphate) we have tested? The metabolites appear to bind at 
relevant concentrations. The crystallographic structure of the homologous human dPGM-
B was solved with citrate bound in the active site (Yanli Wang et al., 2005). The binding 
mode of citrate is similar to the tetravanadate found in E. coli dPGM and was predicted to 
be similar to the binding mode of 3-phosphoglycerate (Yanli Wang et al., 2005). Further, 
human dPGM-B was also found to convert PEP to pyruvate and retain the phosphoryl 
group on His11 (human dPGM numbering) in rapidly proliferating cells (Vander Heiden 
et al., 2010). This suggests that a change in pH, metabolite concentration, or post 
translational modification could alter the activity of dPGM. We tested whether dPGM 
was able to hydrolyze ATP by monitoring ATP in the presence of dPGM by 32P NMR. 
The three peaks of ATP shift in the presence of dPGM relative to ATP alone, which 
indicates binding, but the peaks did not change over the period of 24 hours (data not 
shown); we did not detect any hydrolysis of ATP to ADP. We observed that dPGM 








binding observed for kinases,(Johnson, Lowe, Noble, & Owen, 1998; Karthikeyan et al., 
2003) ATP-binding cassettes,(Davidson, Dassa, Orelle, & Chen, 2008) and P-type 
ATPases, (Banci et al., 2010; Bublitz, Morth, & Nissen, 2011) which bind Mg2+-chelated 
ATP. Therefore, ATP binding to dPGM is not for the common uses of ATP in 
biochemical reactions such as hydrolysis or phosphotransfer. We only observed 
stabilizing effects of the metabolites on E. coli dPGM and the most probable 
physiological effect of the interactions appears to be competitive inhibition.  
 
E. coli dPGM has evolved to bind many abundant anions and enhance its conformational 
cooperativity by promoting the dimeric form over a partially unfolded, monomeric 
intermediate. A theoretical model of the evolutionary effects of random mutation predicts 
that proteins may frequently evolve nonfunctional binding sites that aid in stability 
(Manhart & Morozov, 2015). Even when fitness is determined solely by biochemical 
activities of a protein, more stable proteins are selected through evolution because 
promoting the native state promotes activity. Marginally stable proteins are predicted to 
evolve more interactions with abundant solutes to increase the stability of the protein in 
its physiological milieu and ultimately, promote the protein’s function (Manhart & 
Morozov, 2015). Mutations that favor intrinsic stability tend to result in a loss of function 
(Beadle & Shoichet, 2002; Meiering, Serrano, & Fersht, 1992; Shoichet, Baase, Kuroki, 
& Matthews, 1995). Non-substrate ligand binding offers an alternative way to gain 
conformational stability without suppressing enzyme function other than an increase in 
Km when binding is competitive with substrate. As discussed above, the increase in Km 








be substantially destabilized in the cell environment in a sequence-dependent manor 
(Danielsson et al., 2015; Miklos, Sarkar, Wang, & Pielak, 2011). Destabilization appears 
to occur because many proteins can bind portions of the unfolded sequence and promote 
the unfolded state (Danielsson et al., 2015). Simulations are beginning to take on the task 
of answering how in vitro results translate to in vivo conditions with a focus on the effect 
of crowding (Frembgen-Kesner & Elcock, 2013; McGuffee & Elcock, 2010). In addition 
to crowding and interacting with other proteins, our results and a number of screens for 
protein-metabolite interactions (Li et al., 2010; Link, Kochanowski, & Sauer, 2013; 
Orsak et al., 2011; Roelofs, Wang, Sintim, & Lee, 2011), highlight the impact non-
substrate metabolite and ion binding can have in governing protein stability in the cellular 
environment. 
 
4.3 Experimental Procedures 
4.3.1 Preparation of purified dPGM 
dPGM was over-expressed in E. coli BL21 (DE3) pLysS as previously described 
(Chapter 2). All dPGM variants were purified through two rounds of anion exchange 
chromatography with dialysis before the second round, as previously detailed (Chapter 2) 
(Chapter 2). The purity of dPGM was determined by SDS-PAGE. The final concentration 
of dPGM was determined by absorbance at 280 nm using an extinction coefficient 
estimated from the amino acid composition (Pace et al., 1995). Mutagenesis to produce 
the dPGM variants was carried out previously (Chapter 2, Chapter 3). Protein stocks were 









4.3.2 Equilibrium unfolding 
Urea-induced equilibrium unfolding of dPGM was monitored by intrinsic tryptophan 
fluorescence. For all experiments 0.030 mg/mL dPGM was prepared in 20 mM 
TrisHC−NaOH buffer (pH 8.0) containing varying concentrations of urea (0 – 5 M). The 
urea concentrations were determined from the refractive index (Pace, 1986). Samples 
were filtered through a 0.2 µm filter and equilibrated overnight at 25°C prior to 
spectroscopy. Fluorescence emission spectra spanning 320 to 400 nm were obtained with 
a FlouroMax-3 fluorimeter (Horiba Jobin Yvon; Edison New Jersey, NJ) using an 
excitation wavelength of 280 nm. During data collection the samples were maintained at 
25°C.  
 
The equilibrium unfolding data is analyzed as intensity-weighted average wavelength 
(IWAW) as previously described (Chapter 2). The data was fit with a three-state model 
detailed in scheme 1: 
 
  
 Scheme 1 
 
Fitting was carried out as previously described using OriginPro 8.5.1 (OriginLab; 
Northampton, MA) to determine m-values and the free energy difference between states, 








intermediate state, the dPGM concentration, and both m-values are shared amongst all 
data sets.  
 
4.3.3 Isothermal titration calorimetry 
For ITC, the dPGM samples were prepared at 42 μM (1.2 mg/mL) and dialyzed against 
20 mM TrisHCl−NaOH buffer (pH 8.0) under several salt conditions: 5.0 mM MgCl2, 
0.10 M NaCl, 5.0 MgCl2 and 0.10 M NaCl. After dialysis, the dPGM concentration was 
determined by absorbance at 280 nm. ATP (Sigma-Aldrich; St. Louis, MO) was prepared 
at a concentration of 2.0 mM in the dialysis buffer. The heat evolution was monitored 
with A MicroCal iTC200 calorimeter (GE Healthcare Life Sciences; Piscataway, NJ) 
upon ATP titration. ATP was titrated through 21 injections of 0.40 mM ATP with 3-
minute intervals. The resulting thermograms were automatically integrated by NITPIC 
(Keller et al., 2012) and fit using SEDPHAT (https://sedfitsedphat.nibib.nih.gov).  
 
4.3.4 Estimating the apparent Kd for dPGM−metabolite binding in the presence of a 
competitive cation 
We derived a simple model to estimate the apparent Kd (Kd
app) that would be observed if 
dPGM and Mg2+ compete with one another to bind ATP (eq 4.1). When dPGM, ATP, 



























where [P], [ATP], and [Mg2+] are the concentrations of free dPGM, ATP, and Mg2+, 
respectfully. [P∙ATP] and [Mg2+∙ATP] are the concentrations of ATP-bound dPGM and 
Mg2+, respectfully. Mass conservation dictates that the total concentrations of P, ATP, 
and Mg2+ (Pt, [ATP]0; and [Mg
2+]0, respectfully) are defined as follows:  
 
    ATPPPPt   (4.4) 
 
        ATPPATPMgATPATP  20  (4.5) 
 
      ATPMgMgMg   2202  (4.6) 
 
Because the concentration of dPGM is low (42 μM during ITC), even if all dPGM are 
saturated by ATP, the concentration of free ATP is 10-fold larger and is not greatly 
reduced by binding to dPGM. Therefore, we assume that the term [P∙ATP] is negligible 
in eq 4.5. Then, [Mg2+∙ATP] = [ATP]0 − [ATP]. Because Mg
2+ is in excess compared to 
ATP and present at a concentration 50-fold greater than the Kd for Mg
2+∙ATP, we also 
make the assumption that all ATP is bound so that [Mg2+∙ATP] ≈ [ATP]0. Given this 
assumption, eq 6 can be solved for [Mg2+]: 
 
      0022 ATPMgMg    (4.7) 
 


















 1  (4.8) 
 

















































app is defined as the concentration of ATP where half of the dPGM monomers appear to 
be bound. When [ATP]0 = Kd













f  (4.11) 
 
Substitution of eq 4.11 into eq 4.10, with [ATP]0 = Kd
app, results in the competitive 





















− 2.49 ± 0.08 11.6 ± 0.1 − 1.9 ± 0.1 6.6 ± 0.5 
Citrate − 17.7 ± 0.3 6.1 ± 0.3 − 5.9 ± 0.5 
PEP − 18.3 ± 0.3 6.7 ± 0.3 − 5.7 ± 0.5 
aAll metabolite concentrations are 1.0 mM. 


























− 0 5.0 3.09 ± 0.05 13.0 ± 0.1 − 1.65 ± 0.03 5.5 ± 0.1 
ATP 0 5.0 − 15.6 ± 0.1 2.6 ± 0.1 − 5.5 ± 0.1 
Citrate 0 5.0 − 15.7 ± 0.1 2.7 ± 0.1 − 5.5 ± 0.1 
− 0.10 0 2.5 ± 0.1 13.5 ± 0.3 − 1.5 ± 0.1 4.6 ± 0.5 
ATP 0.10 0 − 19.0 ± 0.4 5.5 ± 0.5 − 3.8 ± 0.7 
Citrate 0.10 0 − 16.9 ± 0.3 3.4 ± 0.4 − 4.2 ± 0.5 
− 0.10 5.0 2.88 ± 0.04 14.5 ± 0.1 − 2.1 ± 0.1 6.7 ± 0.4 
ATP 0.10 5.0 − 15.5 ± 0.1 1.0 ± 0.1 − 6.8 ± 0.4 
Citrate 0.10 5.0 − 15.3 ± 0.1 0.8 ± 0.1 − 6.7 ± 0.4 
a All metabolite concentrations are 1.0 mM. 


























c 2.99 ± 0.02 13.68 ± 0.4 1.97 ± 0.05 1.95 ± 0.06 6.1 ± 0.2 25.9 ± 0.4 
NaCld 2.61 ± 0.02 14.02 ± 0.04 2.31 ± 0.05 1.94 ± 0.04 6.5 ± 0.2 27.0 ± 0.4 
KCld 2.62 ± 0.03 13.90 ± 0.06 2.19 ± 0.07 2.2 ± 0.2 7.4 ± 0.8  29 ± 2 
NaBrd 2.82 ± 0.06 14.6 ± 0.2 2.9 ± 0.2 2.1 ± 0.1 6.4 ± 0.6 27 ± 1 
NaFd 2.77 ± 0.05 14.18 ± 0.09 2.47 ± 0.09 2.3 ± 0.1 8.0 ± 0.5 30 ± 1 
Na2SO4
c,e 2.48 ± 0.04 16.2 ± 0.1  4.5 ± 0.1 1.59 ± 0.07 5.0 ± 0.3 26.2 ± 0.6 
a ΔΔGI−N°= ΔGI−N°(Salt) − ΔGI−N°(no salt) 
b ΔGU−N° = ΔGI−N°+2(ΔGU−I°) 
c Equilibrium unfolding was performed with 33.3 mM salt. 
d Equilibrium unfolding was performed with 0.10 M salt. 








Table 4.4 Thermodynamic parameters of dPGM in the presence of 0 – 0.5 M NaCl. 
a ΔΔGI−N°= ΔGI−N°(NaCl) − ΔGI−N°(no salt) 


















0 2.61 ± 0.02 11.71 ± 0.03 − 1.94 ± 0.04 6.8 ± 0.2 25.3 ± 0.4 
20 − 12.49 ± 0.03 0.78 ± 0.04 − 6.6 ± 0.2 25.7 ± 0.4 
50 − 13.35 ± 0.04 1.64 ± 0.05 − 6.5 ± 0.2 26.4 ± 0.4 
100 − 14.02 ± 0.04 2.31 ± 0.05 − 6.5 ± 0.2 27.0 ± 0.4 
200 − 14.63 ± 0.05 2.92 ± 0.06 − 6.6 ± 0.2 27.8 ± 0.4 
























0 2.83 ± 0.02 8.28 ± 0.02 – 1.66 ± 0.01 5.65 ± 0.01 
0.10 – 10.03 ± 0.03 1.75 ± 0.04 – 5.39 ± 0.03 
0.20 – 10.40 ± 0.03 2.12 ± 0.04 – 5.40 ± 0.04 
0.50 – 10.90 ± 0.03 2.63 ± 0.04 – 5.76 ± 0.04 
K99A 
0 2.79 ± 0.03 14.06 ± 0.06 – 2.09 ± 0.08 7.5 ± 0.3 
0.020 – 14.82 ± 0.07 0.76 ± 0.09 – 7.2 ± 0.3 
0.050 – 15.43 ± 0.07 1.37 ± 0.09 – 7.1 ± 0.3 
0.10 – 15.81 ± 0.07 1.75 ± 0.09 – 7.1 ± 0.3 
0.20 – 16.38 ± 0.08 2.3 ± 0.1 – 7.3 ± 0.3 
R115A 
0 2.89 ± 0.04 15.2 ± 0.1 – 2.2 ± 0.1 8.0 ± 0.5 
0.020 – 16.1 ± 0.1 0.9 ± 0.1 – 7.7 ± 0.5 
0.050 – 16.7 ± 0.1 1.5 ± 0.1 – 7.5 ± 0.4 
0.10 – 17.2 ± 0.1 2.0 ± 0.1 – 7.6 ± 0.4 
0.20 – 17.6 ± 0.1 2.4 ± 0.1 – 7.6 ± 0.4 
K222A 
0 2.61 ± 0.02 11.79 ± 0.03 – 1.87 ± 0.02 6.01 ± 0.08 
0.020 – 12.75 ± 0.04 0.96 ± 0.05 – 5.81 ± 0.07 
0.050 – 13.40 ± 0.04 1.61 ± 0.05 – 5.76 ± 0.07 
0.10 – 14.21 ± 0.05 2.42 ± 0.06 – 5.74 ± 0.07 
0.20 – 14.84 ± 0.05 3.05 ± 0.06 – 5.80 ± 0.07 
















Figure 4.1 Effect of citrate and PEP on the equilibrium unfolding of dPGM 
Equilibrium unfolding of dPGM was performed in the presence of 1.0 mM Citrate ( ) 
and 1.0 mM PEP (■) and the data was fit globally along with equilibrium unfolding of 
dPGM without ligand using eq 2.4 (solid lines) (Table 4.1). Fitting results for the 
equilibrium unfolding of dPGM without ligand and in the presence of 1.0 mM ATP are 













Figure 4.2 Effect of a metabolite on the equilibrium unfolding of dPGM in the presence of 
salt.  
Equilibrium unfolding of dPGM was performed in the presence and absence of 1.0 mM 
citrate ( ) or 1.0 mM ATP (●) under three salt conditions: (A) 5.0 mM MgCl2, (B) 0.10 M 
NaCl, (C) 5.0 mM MgCl2 and 0.10 M NaCl. Under each salt condition data were fit 
globally along with the equilibrium unfolding of dPGM without ligand using eq 2.4 (solid 
lines), and the results are listed in Table 4.2. Fitting results for the equilibrium unfolding of 
dPGM without added salt, in the presence and absence of 1.0 mM ATP, are shown (dashed 
















      
Figure 4.3 The effect of salt on ATP binding to dPGM  
The heat evolution upon ATP binding to dPGM was monitored by isothermal titration 
calorimetry in the presence of 5.0 mM MgCl2 (A) and 0.10 M NaCl (B). ATP was titrated 
in to the ITC cell containing dPGM in 21 injections and the reconstructed thermograms and 
















Figure 4.4 Effect of anions on the equilibrium unfolding of dPGM at an ionic strength of 
0.10 M. 
Equilibrium unfolding of dPGM was monitored in the presence of 33.3 mM MgCl2 (●), 
0.10 M KCl ( ), 0.10 M NaF (▲), 0.10 M NaBr ( ), and 33.3 mM Na2SO4 (■). Data were 
fit with eq 2.4 (─) and normalized using eq 2.5 for proper comparison. For a three-state 
fitting of the equilibrium unfolding of dPGM in the presence of Na2SO4, the data were fit 
globally along with equilibrium unfolding of dPGM without added salt (Chapter 2). The 
fitting results for the equilibrium unfolding of dPGM in the presence of 0.10 M NaCl 
















Figure 4.5 Effect of NaCl on the equilibrium unfolding of dPGM. 
Equilibrium unfolding of dPGM was monitored with NaCl at 0 M (○), 0.02 M (■), 0.05 
M (), 0.10 M (▲), 0.20 M ( ) and 0.50 M (●). Data were fit globally with eq 2.4 (─), 
and the fitting results are listed in Table 4.4. For proper comparison, IWAWs were 















Figure 4.6 Structure of dPGM showing chloride binding and sites of mutation 
The crystallographic structure of dPGM (PDB entry 1E59) is shown with the side chains 
that were probed by for mutation displayed (tan) and labeled. A chloride ion (green) is 
buried in the dimer interface and hydrogen bonds with Trp67. Lys99 and Arg115 form 

















Figure 4.7 Effect of NaCl of the equilibrium unfolding of dPGM variants. 
(A) Equilibrium unfolding of W67A dPGM was monitored without added salt (○) and 
with 0.10 M NaCl (▲), 0.20 M NaCl ( ), and 0.50 M NaCl (●). The equilibrium 
unfolding of K99A dPGM (B), R115A dPGM (C), and K222A dPGM (D) was monitored 
in presence of NaCl at 0.020 M (■), 0.050 M (), 0.10 M (▲), and 0.20 M ( ). The 
data for each dPGM variant were fit globally (solid lines) with eq 2.4 and the results are 
listed in Table 4.5. The fitting results for the equilibrium unfolding of wild-type dPGM in 










CHAPTER 5. IMPLICATIONS OF THE INVESTIGATION  
5.1 Cofactor-dependant phosphoglycerate mutases 
Our investigation with E. coli dPGM has revealed that the protein can populate a partially 
unfolded intermediate, but many metabolites and anions found within the cytosol 
suppress partial unfolding. Because the intermediate is less accessible in a physiological 
milieu, dPGM seems to have evolved to avoid populating the intermediate. If the 
intermediate is undesirable, than it is intriguing that dPGM evolved with such a stable 
core. The stable core of dPGM, which remains folded in the intermediate state, may 
provide an advantage during protein folding. We observed that a majority of the dimer 
interface is formed in the intermediate state. If dimerization and folding of the loop 
region is rate-limiting, the stability of the dPGM core may prevent unfolding from 
occurring before dimerization. Prior to dimerization, dPGM is readily digested by 
protease, as the monomeric intermediate was digested when the equilibrium unfolding of 
dPGM was monitored by pulse proteolysis (Chang et al., 2012). Clearly, the fully folded 
is required to ensure the structural integrity of dPGM. Future investigations on the effect 
of ligand binding and mutation on the kinetics of dPGM would be essential to understand 
the rate limiting step in folding and how the process of folding is influenced by the 








The secondary structure and active site of dPGM is well conserved across E. coli, S. 
cerevisiae, S. pombe, and human brain dPGM, with the key differences being localized to 
subunit interfaces (Bond et al., 2001). The residues we chose for mutation are strictly 
conserved amongst the four species. Active site residues Lys99, Arg115, and Arg116 
(Jacqueline Nairn et al., 2000; Rigden et al., 1999b) are involved in substrate binding and 
Arg9 is implicated in catalysis (Bond et al., 2002; Jacqueline Nairn et al., 2000). The 
native function of these residues is to interact with phosphate and carboxylate groups of 
2,3-BPG, 2-PG, and 3-PG. The conservation between the active sites of all the homologs 
suggests that all four dPGMs could bind ATP, and other anionic metabolites, through the 
same residues. In addition to E. coli dPGM, ATP has been shown to bind to S. cerevisiae 
dPGM in cell lysate (Tran et al., 2014). Several polyanionic inhibitors were demonstrated 
to compete with 2,3-BPG binding to both S. pombe and S. cerevisiae dPGM and were 
shown to occupy the active site cleft of S. cerevisiae dPGM (Rigden, Walter, Phillips, & 
Fothergill-Gilmore, 1999a); the inhibitors interacted with residues Arg115 and Arg116 
(E. coli numbering) of S. cerevisiae. The crystallographic structure of human dPGM has 
been solved with citrate occupying the active site (Yanli Wang et al., 2005). The binding 
mode of citrate is similar to that of the tetravanadate and ATP (Figure 2.6) with citrate 
also forming hydrogen bonds with Lys99 and Arg115 (E. coli numbering) (Yanli Wang 
et al., 2005). Therefore, ATP, other anionic metabolites, and anions, can likely bind 










Homologous dPGMs may show activity for some of the anionic metabolites under the 
right conditions. For example, human dPGM has been shown to convert PEP to pyruvate 
in rapidly proliferating cells (Vander Heiden et al., 2010). Post-translational 
modifications are also used to regulate dPGM activity and may alter interactions with 
metabolites. Phosphorylation of Tyr26 (Tyr25 by E. coli numbering) in the loop region of 
human brain dPGM increases the stability and activity of dPGM. Our investigation shows 
that the phosphorylation event is likely to only form new interactions in the loop region 
and should increase ΔGI–N°. If a dPGM does display low activity for a metabolite, a post-
translational modification could stabilize the conformations with greatest activity for the 
metabolite. This event would increase the apparent activity of dPGM for the metabolite. 
A simple function of some of the metabolites could be negative feedback by competitive 
inhibition to halt glycolysis. Both ATP and PEP can bind in the dPGM active site and are 
produced during glycolysis, downstream of dPGM. If the metabolite concentrations are 
high, additional glycolysis is not an immediate concern for the cell, and the metabolites 
may out-compete 3-phosphoghlycerate binding and inactivate dPGM, slowing glycolysis. 
Additional studies with homologous dPGMs could shed light on this topic as well as 
illuminating whether the energetic linkage between ligand binding and oligomerization is 
conserved by homologous dPGMs. 
 
5.2 dPGM as a model system for folding studies 
E. coli dPGM presents a wonderful model system to investigate the folding of oligomeric 
protein. Current model proteins are highly biased in favor of small monomeric proteins, 








Dimeric proteins are the most abundant form in the E coli proteome (Braselmann et al., 
2013) and many dimeric proteins have been found to populate intermediates (Rumfeldt et 
al., 2008). The model proteins do not reflect the abundance of proteins in the proteome, 
many of which do not appear to fold reversibly. Our investigation on dPGM shows that 
non-substrate metabolite binding can be useful to resist unfolding or partial unfolding. 
However, dPGM has even more to offer as a model system for investigating the 
energetics and kinetics of protein folding. Because the intermediate state of dPGM is 
relatively stable and clearly distinguishable by optical spectroscopy, its properties can be 
studied more readily than most intermediates. dPGM is also fairly easy to purify and the 
protein folds well, for we never detected signs of aggregation. The sensitivity of dPGM to 
its chemical environment allows the experimentalist to modify ΔGI–N° with ease. These 
factors make dPGM a great model system to probe the folding of oligomeric proteins. 
Using dPGM, for example, the folding pathway of an oligomeric protein could be 
examined to help clarify the debate over whether folding proceeds via multiple routes or 
a single pathway. Further, dPGM would allow the investigators to analyze the 
dependency of the folding pathway of the chemical environment or on the magnitude of 
ΔGI–N°.  
 
5.3 Implications for oligomeric protein design  
The partitioning of the cooperative subunits of dPGM and the energetic linkage between 
ligand binding and dimerization can be used as guidelines for oligomeric protein design. 
Two concepts seem important to the energetics of dPGM: partitioning between the stable 








interface between stable and unstable cooperative subunits. The least stable subunit of 
dPGM (the loop region) folds independently from the stable subunits and mutations in 
the least stable subunit, do not alter the stability of the stable subunits. Therefore, there is 
little interaction between the least stable subunit and the stable subunits. This partitioning 
allows the least stable subunit to change conformations and to function as a switch, while 
the stable subunits ensure that the protein remains relatively stable. Partitioning the active 
site and oligomeric interface between stable and unstable subunits ensures that a portion 
of the binding site will be pre-formed or stable, while another portion is dynamic or 
unfolded. The pre-formed, stable portion of the binding site promotes initial interactions 
with the ligand or binding partner. After association, a change in the dynamics or fold of 
the unstable portion of the binding site yields high affinity binding and transmits 
information about the binding event to the residues that are coupled with the unstable 
region. For dPGM, both the active site and dimer interface are partitioned between the 
stable core and the unstable loop region.  
 
To mimic the energetics of dPGM, a protein could be designed with a stable core and an 
unstable binding region. Novel activities and active sites have been designed in a protein; 
thirty two de novo Retro-adolases were designed with varying protein folds (Jiang et al., 
2008). That is, different structures gave rise to the same activity. Then, simple proteins 
could be designed with an active site and an oligomer interface with no regard for 
partitioning. The topology of the designed proteins could be analyzed and then the 
proteins can be rethreaded to connect the secondary structural units with a novel topology 








the proteins into two portions with minimal interactions between each. One region, the 
least stable, will include most of the substrate binding residues and the least stable 
portion of the oligomer interface. Then, folding of the stable subunit will prime the 
proteins for oligomerization and ligand binding and either event should promote the other. 
Such a design feat is currently incredibly complicated. However, computational tools are 
rapidly developing to design well folded de novo protein (Mitra, Shultis, & Zhang, 2013). 
By analyzing the energetics of naturally occurring proteins, such as dPGM, we will 
hopefully be able to engineer de novo oligomeric protein with functions that are sensitive 
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